
<html lang="en"     class="pb-page"  data-request-id="c14ea1f0-684d-429c-9a85-a6f8639cabe5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm800832q;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2008.51.issue-19;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor Activity" /></meta><meta name="dc.Creator" content="Upender  Velaparthi" /></meta><meta name="dc.Creator" content="Mark  Wittman" /></meta><meta name="dc.Creator" content="Peiying  Liu" /></meta><meta name="dc.Creator" content="Joan M.  Carboni" /></meta><meta name="dc.Creator" content="Francis Y.  Lee" /></meta><meta name="dc.Creator" content="Ricardo  Attar" /></meta><meta name="dc.Creator" content="Praveen  Balimane" /></meta><meta name="dc.Creator" content="Wendy  Clarke" /></meta><meta name="dc.Creator" content="Michael W.  Sinz" /></meta><meta name="dc.Creator" content="Warren  Hurlburt" /></meta><meta name="dc.Creator" content="Karishma  Patel" /></meta><meta name="dc.Creator" content="Lorell  Discenza" /></meta><meta name="dc.Creator" content="Sean  Kim" /></meta><meta name="dc.Creator" content="Marco  Gottardis" /></meta><meta name="dc.Creator" content="Ann  Greer" /></meta><meta name="dc.Creator" content="Aixin  Li" /></meta><meta name="dc.Creator" content="Mark  Saulnier" /></meta><meta name="dc.Creator" content="Zheng  Yang" /></meta><meta name="dc.Creator" content="Kurt  Zimmermann" /></meta><meta name="dc.Creator" content="George  Trainor" /></meta><meta name="dc.Creator" content="Dolatrai  Vyas" /></meta><meta name="dc.Description" content="We previously reported that 1 (BMS-536924), a benzimidazole inhibitor of the insulin-like growth factor-1 receptor, had demonstrated in vivo antitumor activity. This lead compound was found to have..." /></meta><meta name="Description" content="We previously reported that 1 (BMS-536924), a benzimidazole inhibitor of the insulin-like growth factor-1 receptor, had demonstrated in vivo antitumor activity. This lead compound was found to have..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 3, 2008" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800832q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800832q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800832q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800832q" /></link>
        
    
    

<title>Discovery and Evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800832q" /></meta><meta property="og:title" content="Discovery and Evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/large/jm-2008-00832q_0002.jpeg" /></meta><meta property="og:description" content=" We previously reported that 1 (BMS-536924), a benzimidazole inhibitor of the insulin-like growth factor-1 receptor, had demonstrated in vivo antitumor activity. This lead compound was found to have potent CYP3A4 inhibition, CYP3A4 induction mediated by PXR transactivation, poor aqueous solubility, and high plasma protein binding. Herein we disclose the evolution of this chemotype to address these issues. This effort led to 10 (BMS-695735), which exhibits improved ADME properties, a low risk for drug−drug interactions, and in vivo efficacy in multiple xenograft models." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800832q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800832q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800832q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800832q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800832q&amp;href=/doi/10.1021/jm800832q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 5897-5900</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm8008986" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Letter</span><a href="/doi/10.1021/jm800608s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Evaluation of 4-(2-(4-chloro-1<i>H</i>-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)pyridin-2(1<i>H</i>)-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Upender++Velaparthi">Upender Velaparthi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Wittman">Mark Wittman</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peiying++Liu">Peiying Liu</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joan+M.++Carboni">Joan M. Carboni</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francis+Y.++Lee">Francis Y. Lee</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ricardo++Attar">Ricardo Attar</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Praveen++Balimane">Praveen Balimane</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wendy++Clarke">Wendy Clarke</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+W.++Sinz">Michael W. Sinz</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Warren++Hurlburt">Warren Hurlburt</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karishma++Patel">Karishma Patel</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lorell++Discenza">Lorell Discenza</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean++Kim">Sean Kim</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Gottardis">Marco Gottardis</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ann++Greer">Ann Greer</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aixin++Li">Aixin Li</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Saulnier">Mark Saulnier</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zheng++Yang">Zheng Yang</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kurt++Zimmermann">Kurt Zimmermann</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George++Trainor">George Trainor</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dolatrai++Vyas">Dolatrai Vyas</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 203-677-7910. Fax: 203-677-7702. E-mail: <a href="/cdn-cgi/l/email-protection#394c495c575d5c4b174f5c555849584b4d5150795b544a175a5654"><span class="__cf_email__" data-cfemail="c7b2b7a2a9a3a2b5e9b1a2aba6b7a6b5b3afae87a5aab4e9a4a8aa">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Discovery Chemistry, Bristol-Myers Squibb Co., Wallingford, Connecticut.</div><div class="corresp-fn" id="afn2">‡Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Wallingford, Connecticut.</div><div class="corresp-fn" id="afn3">§Department of Oncology Drug Discovery, Bristol-Myers Squibb Co., Princeton, New Jersey.</div><div class="corresp-fn" id="afn4">∥Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Princeton, New Jersey.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800832q&amp;href=/doi/10.1021%2Fjm800832q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 5897–5900</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 3, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 March 2008</li><li><span class="item_label"><b>Published</b> online</span>3 September 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 October 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800832q" title="DOI URL">https://doi.org/10.1021/jm800832q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5897%26pageCount%3D4%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DUpender%2BVelaparthi%252C%2BMark%2BWittman%252C%2BPeiying%2BLiu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D19%26contentID%3Djm800832q%26title%3DDiscovery%2Band%2BEvaluation%2Bof%2B4-%25282-%25284-chloro-1H-pyrazol-1-yl%2529ethylamino%2529-3-%25286-%25281-%25283-fluoropropyl%2529piperidin-4-yl%2529-4-methyl-1H-benzo%255Bd%255Dimidazol-2-yl%2529pyridin-2%25281H%2529-one%2B%2528BMS-695735%2529%252C%2Ban%2BOrally%2BEfficacious%2BInhibitor%2Bof%2BInsulin-like%2BGrowth%2BFactor-1%2BReceptor%2BKinase%2Bwith%2BBroad%2BSpectrum%2Bin%2BVivo%2BAntitumor%2BActivity%26numPages%3D4%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5900%26publicationDate%3DOctober%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800832q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2141</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800832q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Upender&quot;,&quot;last_name&quot;:&quot;Velaparthi&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Wittman&quot;},{&quot;first_name&quot;:&quot;Peiying&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Joan&quot;,&quot;last_name&quot;:&quot;M. Carboni&quot;},{&quot;first_name&quot;:&quot;Francis&quot;,&quot;last_name&quot;:&quot;Y. Lee&quot;},{&quot;first_name&quot;:&quot;Ricardo&quot;,&quot;last_name&quot;:&quot;Attar&quot;},{&quot;first_name&quot;:&quot;Praveen&quot;,&quot;last_name&quot;:&quot;Balimane&quot;},{&quot;first_name&quot;:&quot;Wendy&quot;,&quot;last_name&quot;:&quot;Clarke&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;W. Sinz&quot;},{&quot;first_name&quot;:&quot;Warren&quot;,&quot;last_name&quot;:&quot;Hurlburt&quot;},{&quot;first_name&quot;:&quot;Karishma&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;Lorell&quot;,&quot;last_name&quot;:&quot;Discenza&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Gottardis&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;Greer&quot;},{&quot;first_name&quot;:&quot;Aixin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Saulnier&quot;},{&quot;first_name&quot;:&quot;Zheng&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Kurt&quot;,&quot;last_name&quot;:&quot;Zimmermann&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;Trainor&quot;},{&quot;first_name&quot;:&quot;Dolatrai&quot;,&quot;last_name&quot;:&quot;Vyas&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;5897-5900&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800832q&quot;},&quot;abstract&quot;:&quot;We previously reported that 1 (BMS-536924), a benzimidazole inhibitor of the insulin-like growth factor-1 receptor, had demonstrated in vivo antitumor activity. This lead compound was found to have potent CYP3A4 inhibition, CYP3A4 induction mediated by PXR transactivation, poor aqueous solubility, and high plasma protein binding. Herein we disclose the evolution of this chemotype to address these issues. This effort led to 10 (BMS-695735), which exhibits improved ADME properties, a low risk for drug−drug interactions, and in vivo efficacy in multiple xenograft models.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800832q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800832q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800832q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800832q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800832q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800832q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800832q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800832q&amp;href=/doi/10.1021/jm800832q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800832q" /></input><a href="/doi/pdf/10.1021/jm800832q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (205 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800832q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800832q%26sid%3Dliteratum%253Aachs%26pmid%3D18763755%26genre%3Darticle%26aulast%3DVelaparthi%26date%3D2008%26atitle%3DDiscovery%2Band%2BEvaluation%2Bof%2B4-%25282-%25284-chloro-1H-pyrazol-1-yl%2529ethylamino%2529-3-%25286-%25281-%25283-fluoropropyl%2529piperidin-4-yl%2529-4-methyl-1H-benzo%255Bd%255Dimidazol-2-yl%2529pyridin-2%25281H%2529-one%2B%2528BMS-695735%2529%252C%2Ban%2BOrally%2BEfficacious%2BInhibitor%2Bof%2BInsulin-like%2BGrowth%2BFactor-1%2BReceptor%2BKinase%2Bwith%2BBroad%2BSpectrum%2Bin%2BVivo%2BAntitumor%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D19%26spage%3D5897%26epage%3D5900%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/medium/jm-2008-00832q_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/large/jm-2008-00832q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800832q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We previously reported that <b>1</b> (BMS-536924), a benzimidazole inhibitor of the insulin-like growth factor-1 receptor, had demonstrated in vivo antitumor activity. This lead compound was found to have potent CYP3A4 inhibition, CYP3A4 induction mediated by PXR transactivation, poor aqueous solubility, and high plasma protein binding. Herein we disclose the evolution of this chemotype to address these issues. This effort led to <b>10</b> (BMS-695735), which exhibits improved ADME properties, a low risk for drug−drug interactions, and in vivo efficacy in multiple xenograft models.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><p class="first">Receptor tyrosine kinases (RTKs) play a central role in signal transduction of cellular functions and aberration of this signaling contributes to a wide range of diseases.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Recent success with inhibiting these RTKs by small molecules has generated considerable interest in the search for additional RTKs for targeted therapeutic intervention.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The insulin-like growth factor-1 receptor (IGF-1R) belongs to the super family of RTKs and has been implicated in the pathophysiology of a several human neoplasms.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The insulin-like growth factor (IGF) family consists of two ligands (IGF-I and IGF-II), two receptors (IGF-1R and IGF-IIR), six high-affinity binding proteins (IGFBP 1−6), which serve to modulate effective serum concentration of IGF-1, and several IGFBP-related proteins. IGF-1 mediates cell signaling through the IGF-1R, which upon binding undergoes conformational changes resulting in the activation of intrinsic tyrosine kinase domain and subsequent multisite autophosphorylation. This phosphorylation step further activates two distinct signaling pathways, namely the Ras/Raf/MEK/ERK and PI3/Akt/mTOR pathways.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> These downstream pathways synergize to promote cellular proliferation, inhibit apoptosis, and increase cell survival. Overexpression and overactivation of IGF-1 and IGF-1R have been demonstrated in a variety of tumors, including glioma, lung, ovary, and breast carcinomas and sarcomas.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Down regulation of IGF-1R function by strategies such as antisense,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> antibody,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and dominant negative mutant<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> approaches was found to interfere with cell growth and proliferation. Additionally, epidemiological studies have also highlighted the importance of IGF-1R in key tumor types by correlating elevated IGF-1 levels with increased risk of developing colon, breast, prostate, and lung tumors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> As a consequence, the identification of IGF-1R inhibitors has recently attracted considerable attention for cancer therapy and several classes of inhibitors have been described.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17">(10-17)</a> While several monoclonal antibodies have entered clinical trials, many small molecule inhibitors are still currently being investigated in the preclinical stages.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></p><p>We have recently reported a small molecule IGF-1R inhibitor <b>1</b> (BMS-536924),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> which demonstrated in vivo efficacy in the IGF-Sal tumor model and xenograft models. Despite its utility as a useful tool compound, the potential to cause drug−drug interactions was considered problematic. Compound <b>1</b> exhibited potent inhibition (<1 μM) against cytochrome P450 3A4 (CYP3A4) and more moderate inhibition against other isozymes (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In a medium-throughput time-dependent inhibition (TDI) assay using recombinant CYP3A4, compound <b>1</b> caused a 6-fold decrease in IC<sub>50</sub> between 5 and 45 min of incubation. Subsequent studies in human liver microsomes showed that compound <b>1</b> inhibited CYP3A4 in a metabolism-dependent manner. Together, these results suggest that <b>1</b> has the potential to interfere with the metabolism of other drugs predominately metabolized by CYP3A4. Furthermore, compound <b>1</b> was found to be a potent transactivator of the pregnane-X-receptor (PXR) (125% of rifampicin at 10 μM). PXR is a xenobiotic nuclear hormone receptor and its activation has been implicated in the induction of CYP3A4, which could potentially result in reduced efficacy of the drug (autoinduction) or concomitantly administered drugs as well as enhanced metabolism-dependent toxicity.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The degree of transactivation noted for <b>1</b> was significant and similar to that found for the positive control rifampicin, which is known to cause clinically significant drug−drug interactions due to induction of CYP3A4. In a follow-up study in primary human hepatocytes, compound <b>1</b> increased CYP3A4 mRNA expression levels as determined by real time-PCR in a dose-dependent manner. Thus, compound <b>1</b>, being both an inhibitor (reversible and time-dependent) and an inducer of CYP3A4, was deemed unsuitable for development due to uncertain clinical outcome. Additional drawbacks of compound <b>1</b> included its poor aqueous solubility (<1 μg/mL) and high plasma protein binding (>99.8% for human and >99.9% for mouse).</p><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Profile for Compounds <b>1</b> and <b>10</b></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"><b>1</b></th><th align="center" valign="middle"><b>10</b></th></tr></thead><tbody><tr valign="top"><td align="left">IGF-1R<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a> IC<sub>50</sub> (μM)</td><td align="left">0.100</td><td align="left">0.034</td></tr><tr valign="top"><td align="left">CYP1A2<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a> IC<sub>50</sub> (μM)</td><td align="left">34<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></td><td align="left">>40</td></tr><tr valign="top"><td align="left">CYP2C9<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a> IC<sub>50</sub> (μM)</td><td align="left">1.2<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></td><td align="left">>40</td></tr><tr valign="top"><td align="left">CYP2C19<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a> IC<sub>50</sub> (μM)</td><td align="left">2.0<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></td><td align="left">34</td></tr><tr valign="top"><td align="left">CYP2D6<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a> IC<sub>50</sub> (μM)</td><td align="left">>40<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></td><td align="left">>40</td></tr><tr valign="top"><td align="left">CYP3A4-BFC<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a> IC<sub>50</sub> (μM)</td><td align="left">0.5<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></td><td align="left">26</td></tr><tr valign="top"><td align="left">CYP3A4-BzRes<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a> IC<sub>50</sub> (μM)</td><td align="left">5.3</td><td align="left">ND</td></tr><tr valign="top"><td align="left">Caco (nm/s)</td><td align="left">18</td><td align="left">109</td></tr><tr valign="top"><td align="left">solubility (μg/mL)</td><td align="left"><1</td><td align="left">137</td></tr><tr valign="top"><td align="left">plasma protein binding (m,%)</td><td align="left">>99.9</td><td align="left">86.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Values represent an average of 10 determinations.</p></div></div></div><p>To improve ADME<a class="ref internalNav" href="#fn1" aria-label="a">a</a> properties, including CYP 3A4 induction and inhibiton so as to minimize clinical drug−drug interactions, we further explored the series and undertook a systematic survey of structure−activity relationship (SAR) studies. In particular, we investigated morpholine replacements on the top left-hand side and phenethylamine side chain on the bottom right-hand side of compound <b>1</b>. Herein we describe the optimization of these regions, leading to the discovery of <b>10</b> (BMS-695735)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> as an orally efficacious antitumor agent devoid of PXR transactivation and CYP3A4 inhibition.</p><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/medium/jm-2008-00832q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/large/jm-2008-00832q_0004.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/large/jm-2008-00832q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800832q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) bis(pinacolato)diborane, PdCl<sub>2</sub>(dppf)<sub>2</sub>, KOAc, DMSO; (b) <b>13</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, LiCl, Na<sub>2</sub>CO<sub>3</sub>, DME; (c) 10% Pd−C/MeOH H<sub>2</sub>, 4-iodo-2-methoxynicotinaldehyde (<b>15)</b>/MeOH; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 3-fluoropropylbromide; (e) 4NHCl/dioxane; (f) 2-(4-chloro-1<i>H</i>-pyrazol-1-yl)ethanamine, Et<sub>3</sub>N/CH<sub>3</sub>CN/85 °C.</p></p></figure><p>The synthesis of compound <b>10</b> began with the commercially available bromonitroaniline <b>11</b>, which was subjected to palladium mediated boronation. The resultant pinacol boronate ester <b>12</b> was subjected to Suzuki reaction with piperidine enol triflate <b>13</b> to yield the coupled product <b>14</b>. Hydrogenation of <b>14</b> and subsequent condensation with the aldehyde <b>15</b> furnished the benzimidazole <b>16</b>. Deprotection of the Boc group followed by alkylation gave fluoropropyl piperidine <b>17</b>. Methoxy cleavage and incorporation of amino pyrazole provided compound <b>10</b>.</p><p>The lead optimization was facilitated by cocrystallization of several inhibitors from this benzimidazole scaffold bound to <div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: ADME, Absorption, Distribution, Metabolism and Excretion; PPB, Plasma Protein Binding; MTD, Maximum tolerated dose; IV, intravenous; PO, per os (oral); F<sub>po</sub>, oral bioavilability; C<sub>max</sub>, maximum concentration; CL<sub>tot</sub>, total clearance; Vss, Steady-state volume of distribution; T<sub>1/2</sub>, Elimination half-life.</p></div> the truncated IGF-IR, which revealed that the morpholine group in <b>1</b> is solvent exposed and therefore could be replaced with other groups to optimize PK properties and reduce CYP inhibition without affecting IGF-1R potency.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Appending various substituted morpholines in general did not improve CYP3A4 inhibition and/or PXR transactivation. Replacing the morpholine with its isosteres such as piperazines and 4-amino piperidines and attenuating the basicity of the distal nitrogen with various groups did not yield an optimal compound that balanced CYP3A4 inhibition, PXR transactivation, and oral exposure. However, a significant improvement was observed in both CYP3A4 inhibition and PXR transactivation when a C-4 connected piperidine was appended on the benzimidazole core in place of morpholine (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Removal of nitrogen atom that connected the heterocycle to the benzimidazole core and replacing it with a carbon appeared to have diminished the affinity for CYP3A4. This modification also eradicated the PXR transactivation associated with <b>1</b>. This was a significant development that could not have been predicted given the paucity of SAR information related to PXR transactivation in the literature.<a onclick="showRef(event, 'cit19b'); return false;" href="javascript:void(0);" class="ref cit19b">(19b)</a></p><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Profile of Carbon attached Piperidine Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/medium/jm-2008-00832q_0003.gif" alt="" id="gr3" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R</th><th align="center" valign="middle" char=".">side chain</th><th align="center" valign="middle" char=".">IGF-1R IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th align="center" valign="middle" char=".">IGF-Sal IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></th><th align="center" valign="middle" char=".">CYP3A4 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl1-fn3" aria-label="c">c</a></th><th align="center" valign="middle" char=".">PXR EC<sub>20</sub> (μM)<a class="ref internalNav" href="#tbl1-fn4" aria-label="d">d</a></th><th align="center" valign="middle" char=".">AUC (μM·h)<a class="ref internalNav" href="#tbl1-fn5" aria-label="e">e</a></th><th align="center" valign="middle" char=".">PPB (%)<a class="ref internalNav" href="#tbl1-fn6" aria-label="f">f</a></th><th align="center" valign="middle" char=".">p<i>K</i><sub>a</sub><a class="ref internalNav" href="#tbl1-fn7" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left"> </td><td align="char" char="."> </td><td align="char" char=".">0.100</td><td align="char" char=".">0.110</td><td align="char" char=".">0.05</td><td align="char" char=".">1.1</td><td align="char" char=".">50.0</td><td align="char" char=".">99.9</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>2</b></td><td align="left">CH<sub>3</sub></td><td align="char" char=".">A</td><td align="char" char=".">0.022</td><td align="char" char=".">0.085</td><td align="char" char=".">14.0</td><td align="char" char=".">>50</td><td align="char" char=".">1.2</td><td align="char" char="."> </td><td align="char" char=".">9.4</td></tr><tr valign="top"><td align="left"><b>3</b></td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OMe</td><td align="char" char=".">A</td><td align="char" char=".">0.018</td><td align="char" char=".">0.217</td><td align="char" char=".">11.0</td><td align="char" char=".">>50</td><td align="char" char=".">0.0</td><td align="char" char="."> </td><td align="char" char=".">8.56</td></tr><tr valign="top"><td align="left"><b>4</b></td><td align="left">CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>F</td><td align="char" char=".">A</td><td align="char" char=".">0.031</td><td align="char" char=".">0.076</td><td align="char" char=".">28.0</td><td align="char" char=".">>50</td><td align="char" char=".">0.0</td><td align="char" char="."> </td><td align="char" char=".">8.87</td></tr><tr valign="top"><td align="left"><b>5</b></td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OMe</td><td align="char" char=".">B</td><td align="char" char=".">0.023</td><td align="char" char=".">0.013</td><td align="char" char=".">7.7</td><td align="char" char=".">>50</td><td align="char" char=".">0.49</td><td align="char" char="."> </td><td align="char" char=".">8.56</td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="left">CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>F</td><td align="char" char=".">B</td><td align="char" char=".">0.020</td><td align="char" char=".">0.040</td><td align="char" char=".">10.0</td><td align="char" char=".">>50</td><td align="char" char=".">0.28</td><td align="char" char="."> </td><td align="char" char=".">8.87</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left">CH<sub>3</sub></td><td align="char" char=".">C</td><td align="char" char=".">0.026</td><td align="char" char=".">0.162</td><td align="char" char=".">40.0</td><td align="char" char=".">>50</td><td align="char" char=".">0.4</td><td align="char" char="."> </td><td align="char" char=".">9.43</td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OH</td><td align="char" char=".">C</td><td align="char" char=".">0.025</td><td align="char" char=".">0.241</td><td align="char" char=".">23.0</td><td align="char" char=".">>50</td><td align="char" char=".">0.1</td><td align="char" char="."> </td><td align="char" char=".">8.56</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OMe</td><td align="char" char=".">C</td><td align="char" char=".">0.018</td><td align="char" char=".">0.046</td><td align="char" char=".">19.5</td><td align="char" char=".">>50</td><td align="char" char=".">1.8</td><td align="char" char=".">96.2</td><td align="char" char=".">8.56</td></tr><tr valign="top"><td align="left"><b>10</b></td><td align="left">CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>F</td><td align="char" char=".">C</td><td align="char" char=".">0.034</td><td align="char" char=".">0.185</td><td align="char" char=".">26.0</td><td align="char" char=".">>50</td><td align="char" char=".">3.7</td><td align="char" char=".">86.9</td><td align="char" char=".">8.87</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Values are reported as the mean of at least two individual determinations, in duplicate; standard deviations ranged from 0.001 to 0.13.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">This cell line is derived from salivary tumors that develop in transgenic mice.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></p></div><div class="footnote" id="tbl1-fn3"><sup>c</sup><p class="last">Values are determined for inhibition of dealkylation of BFC (7-benzoloxy-4-trifluoromethylcoumarin).</p></div><div class="footnote" id="tbl1-fn4"><sup>d</sup><p class="last">Compounds are tested at ten concentrations (50 μM to 2.5 nM, 1:3 serial dilution), and concentrations of compound at which a 20% activation (EC<sub>20</sub>) occur are reported when rifampicin is used as a positive control.</p></div><div class="footnote" id="tbl1-fn5"><sup>e</sup><p class="last">Compounds are evaluated in 4 h exposure studies in mice at 20 mg/kg and formulated as solutions of 80:20 PEG400 and water.</p></div><div class="footnote" id="tbl1-fn6"><sup>f</sup><p class="last">PPB in mouse was determined at 10 μM using equilibrium dialysis.</p></div><div class="footnote" id="tbl1-fn7"><sup>g</sup><p class="last">p<i>K</i><sub>a</sub> values are calculated using ACDlabs software.</p></div></div></div><p>As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, this new carbon linked series showed consistently improved CYP3A4 inhibition and PXR transactivation. Electron withdrawing groups on the terminal piperidine nitrogen such as amides, carbamates, and sulfonamides reduced both enzyme and cell potencies (data not shown). Small alkyl groups on the piperidine provided compounds with good enzyme and cellular potencies. However, oral exposure was almost negligible in the compounds with the phenethylamine side chain (side chain A; compounds <b>2</b>−<b>4</b>). Placing a methoxy group at the <i>para</i> position on the side chain (side chain <b>B</b>) improved enzyme and cellular potencies, but oral exposure still remained low. After extensive investigation, molecules with chloropyrazole (side chain <b>C</b>) generally showed reduced plasma protein binding along with some improvement in oral exposure.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Attenuating the basicity of piperidine nitrogen gave compounds (<b>9</b> and <b>10</b>) with modest oral exposure, reduced plasma protein binding, and good enzyme potency in the biochemical assay. Thus, these two compounds were evaluated in full pharmacokinetic (PK) experiments, with compound <b>10</b> showing favorable oral bioavailability (>100% for mice and 23% for rats) compared to <b>9</b> (10.3% for mice and 2.9% for rats).</p><p>Encouraged by the superior oral bioavailability and reduced plasma protein binding (13.1% free fraction), compound <b>10</b> was selected for further pharmacokinetic characterization in multiple species, kinase selectivity, and in vivo efficacy studies. The pharmacokinetic parameters obtained for <b>10</b> in multiple species are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. In a mouse pharmacokinetic study, compound <b>10</b> was characterized as having a high volume of distribution (<i>V</i><sub>ss</sub> = 18.2 L/kg), excellent bioavailability (132% at 50 mg/kg), high clearance (159 mL/min/kg), and a flat, extended absorption phase out to 6 h. A nonlinear increase in exposure was noted with this compound.</p><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Parameters for <b>10</b> in Multiple Species<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle">mouse</th><th align="center" valign="middle">rat</th></tr></thead><tbody><tr valign="top"><td align="left">IV/PO dose (mg/kg)</td><td align="left">5/50</td><td align="left">2/10</td></tr><tr valign="top"><td align="left"><i>F</i><sub>po</sub> (%)</td><td align="left">>100</td><td align="left">23</td></tr><tr valign="top"><td align="left"><i>C</i><sub>max, po</sub> (μM)</td><td align="left">2.3</td><td align="left">0.20 ± 0.10</td></tr><tr valign="top"><td align="left">CL<sub>tot</sub> (mL/min/kg)</td><td align="left">159</td><td align="left">76 ± 23</td></tr><tr valign="top"><td align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td align="left">18.2</td><td align="left">20 ± 8.8</td></tr><tr valign="top"><td align="left"><i>T</i><sub>1/2</sub> (h)</td><td align="left">2.3</td><td align="left">4 ± 2.4</td></tr></tbody></table><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th align="center">dog</th><th align="center">monkey</th></tr></thead><tbody><tr valign="top"><td align="left">IV/PO dose (mg/kg)</td><td align="left">2/10</td><td align="left">2/10</td></tr><tr valign="top"><td align="left"><i>F</i><sub>po</sub> (%)</td><td align="left">35</td><td align="left">48</td></tr><tr valign="top"><td align="left"><i>C</i><sub>max, po</sub> (μM)</td><td align="left">0.27 ± 0.15</td><td align="left">0.4 ± 0.010</td></tr><tr valign="top"><td align="left">CL<sub>tot</sub> (mL/min/kg)</td><td align="left">23 ± 2.5</td><td align="left">27 ± 3.3</td></tr><tr valign="top"><td align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td align="left">21 ± 5.6</td><td align="left">17 ± 4.9</td></tr><tr valign="top"><td align="left"><i>T</i><sub>1/2</sub> (h)</td><td align="left">10.5 ± 1.9</td><td align="left">7.3 ± 1.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Administered as a solution in PEG400/water (80:20 v/v).</p></div></div></div><p>To better understand the kinase selectivity of <b>10</b>, the compound was evaluated against an in-house kinase panel and was also confirmed to be an ATP-competitive inhibitor. As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, compound <b>10</b> was found to be a potent inhibitor of IGF-1R and IR.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> It also showed a moderate activity against FAK, Lck, and Emt. A greater than 100-fold selectivity was observed for all other receptor and nonreceptor kinase targets found in the panel. To assess ramifications of cross reactivity against T cell kinases such as Lck and Emt, an in vivo MLR (mixed lymphocyte reaction) study was conducted at 50 and 100 mg/kg and <b>10</b> was found to have no effect on CD4 T cell proliferation.</p><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Kinase Selectivity Profile of <b>10</b></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">kinases</th><th align="center" valign="middle" char="."><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a>IC<sub>50</sub> (μM)</th><th align="center" valign="middle">kinases</th><th align="center" valign="middle" char="."><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a>IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="left">IGF-1R</td><td align="char" char=".">0.034</td><td align="left">P38</td><td align="char" char=".">30.97</td></tr><tr valign="top"><td align="left">IR</td><td align="char" char=".">0.072</td><td align="left">MK2</td><td align="char" char=".">>50</td></tr><tr valign="top"><td align="left">FAK</td><td align="char" char=".">0.165</td><td align="left">KDR</td><td align="char" char=".">0.369</td></tr><tr valign="top"><td align="left">PKC-α</td><td align="char" char=".">11.00</td><td align="left">FGFR1</td><td align="char" char="."><5</td></tr><tr valign="top"><td align="left">PKC-δ</td><td align="char" char=".">20.3</td><td align="left">HER1</td><td align="char" char=".">21</td></tr><tr valign="top"><td align="left">PKA-B</td><td align="char" char=".">37.68</td><td align="left">HER2</td><td align="char" char=".">6</td></tr><tr valign="top"><td align="left">CDK2</td><td align="char" char=".">59.07</td><td align="left">Met</td><td align="char" char=".">3.99</td></tr><tr valign="top"><td align="left">IKK</td><td align="char" char=".">>100</td><td align="left">GSK3</td><td align="char" char=".">8.56</td></tr><tr valign="top"><td align="left">Lck</td><td align="char" char=".">0.14</td><td align="left">PDE4</td><td align="char" char=".">4</td></tr><tr valign="top"><td align="left">Akt</td><td align="char" char=".">48.39</td><td align="left">Emt</td><td align="char" char=".">0.37</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> were determined with ATP concentration at 1/2 K<i>m</i> for each kinase.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vivo Antitumor Activity of <b>10</b> against Tumor Xenografts Implanted Subcutaneously in Athymic Mice</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="×" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">tumor model</th><th align="center" valign="middle" char=".">dose (mg/kg)</th><th align="center" valign="middle" char="×">schedule</th><th align="center" valign="middle" char="."><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a>TGI (%)</th></tr></thead><tbody><tr valign="top"><td align="left">IGF-Sal</td><td align="char" char=".">50</td><td align="char" char="×">BID × 5</td><td align="char" char=".">81</td></tr><tr valign="top"><td align="left">Colo205</td><td align="char" char=".">100</td><td align="char" char="×">BID × 21</td><td align="char" char=".">93</td></tr><tr valign="top"><td align="left">JJN3</td><td align="char" char=".">100</td><td align="char" char="×">BID × 21</td><td align="char" char=".">80</td></tr><tr valign="top"><td align="left">Geo</td><td align="char" char=".">100</td><td align="char" char="×">BID × 21</td><td align="char" char=".">73</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Percent tumor growth inhibition determined at the end of treatment (IGF-Sal) or averaged over at least one tumor volume doubling time during a prolonged dosing regimen. Values >50% is considered an active result.</p></div></div></div><p>The encouraging pharmacokinetic profile exhibited by <b>10</b> supported further characterization of the compound in in vivo efficacy studies. Compound <b>10</b> was evaluated in vivo in the constitutively activated IGF-Sal tumor model<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and found to be active when administered orally at 50 mg/kg twice a day for 4 days. Compound <b>10</b> was also found to have activity against several human tumor xenografts grown in nude mice including Colo205 colon carcinoma (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), Geo colon carcinoma, and JJN3 multiple myeloma models. Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> illustrates a comparison of dose-dependent growth inhibition of <b>10</b> and <b>1</b> in the Colo205 tumor model. Oral administration of <b>10</b> on a twice a day schedule of either 50 or 100 mg/kg for 21 days demonstrated antitumor activity, with the activity at 100 mg/kg superior to that of our prototypical lead <b>1</b> dosed at MTD. As a single agent, both of these IGF-1R inhibitors reduced the rate of tumor growth but did not cause tumor regression. Moreover, tumor growth rapidly resumed at the cessation of treatment. These results are suggestive of cytostatic antitumor activity. Compound <b>10</b> also demonstrated synergistic antitumor efficacy in combination with Cetuximab (data not shown). Safety profiling of <b>10</b> showed it to be negative in Ames mutagenicity and SOS chromotest and noncytotoxic in human hepatocyte assays.</p><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/medium/jm-2008-00832q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/large/jm-2008-00832q_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Efficacy of <b>1</b> and <b>10</b> in Colo205 (human colon carcinoma, BID × 21).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/large/jm-2008-00832q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800832q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="last">In summary, we report the continued development of the benzimidazole scaffold and the discovery of C-4 carbon-tethered piperidines with potent IGF-1R inhibition. The work led to the identification of <b>10</b>, a compound with reduced CYP3A4 inhibition and PXR transactivation and thereby lowered the risk for potential for drug−drug interactions. Compound <b>10</b> was also shown to have improved aqueous solubility, reduced plasma protein binding, and efficacy on oral administration in multiple xenograft in vivo models.</p><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9"><a href="/doi/suppl/10.1021/jm800832q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details and analytical data for compound <b>10</b> are included. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800832q/suppl_file/jm800832q_si_001.pdf">jm800832q_si_001.pdf (1.44 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm800832q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Upender Velaparthi</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#621712070c0607104c14070e03120310160a0b22000f114c010d0f"><span class="__cf_email__" data-cfemail="96e3e6f3f8f2f3e4b8e0f3faf7e6f7e4e2feffd6f4fbe5b8f5f9fb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Wittman</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peiying Liu</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joan M. Carboni</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francis Y. Lee</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ricardo Attar</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Praveen Balimane</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wendy Clarke</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael W. Sinz</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Warren Hurlburt</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karishma Patel</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorell Discenza</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean Kim</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Gottardis</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann Greer</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aixin Li</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Saulnier</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng Yang</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kurt Zimmermann</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George Trainor</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dolatrai Vyas</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, Department of Oncology Drug Discovery, Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Route 206 and Province Line Rd, Princeton, New Jersey 08540</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank the Lead Profiling and analytical departments of Bristol-Myers Squibb Company, Wallingford, CT, for generating the CYP inhibition, PXR transactivation, and analytical data.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This manuscript was released ASAP on September 3, 2008 with typographical errors in Table 5. The correct version was released on September 5, 2008.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hubbard, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. T.</span><span> </span><span class="NLM_article-title">Receptor tyrosine kinases: mechanisms of activation and signaling</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1016%2Fj.ceb.2007.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=17306972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=117-123&author=S.+R.+Hubbardauthor=W.+T.+Miller&title=Receptor+tyrosine+kinases%3A+mechanisms+of+activation+and+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor tyrosine kinases: mechanisms of activation and signaling</span></div><div class="casAuthors">Hubbard, Stevan R.; Miller, W. Todd</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-123</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases (RTKs) are essential components of signal transduction pathways that mediate cell-to-cell communication.  These single-pass transmembrane receptors, which bind polypeptide ligands - mainly growth factors - play key roles in processes such as cellular growth, differentiation, metab. and motility.  Recent progress has been achieved towards an understanding of the precise (and varied) mechanisms by which RTKs are activated by ligand binding and by which signals are propagated from the activated receptors to downstream targets in the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg3ej9ekC3hLVg90H21EOLACvtfcHk0lg5c8iX6ZWUZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu78%253D&md5=254110135c0f1a5642441c551d379bef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2007.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2007.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26aulast%3DMiller%26aufirst%3DW.%2BT.%26atitle%3DReceptor%2520tyrosine%2520kinases%253A%2520mechanisms%2520of%2520activation%2520and%2520signaling%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2007%26volume%3D19%26spage%3D117%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Liao, J, J.</span><span> </span><span class="NLM_article-title">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J%2C+J.+Liao&title=Molecular+Recognition+of+Protein+Kinase+Binding+Pockets+for+Design+of+Potent+and+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0li0CHeKF22wQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ%252C%2BJ.%26atitle%3DMolecular%2520Recognition%2520of%2520Protein%2520Kinase%2520Binding%2520Pockets%2520for%2520Design%2520of%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">LeRoith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. T.</span><span> </span><span class="NLM_article-title">The insulin-like growth factor system and cancer</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1016%2FS0304-3835%2803%2900159-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=12767520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFWmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2003&pages=127-137&author=D.+LeRoithauthor=C.+T.+Roberts&title=The+insulin-like+growth+factor+system+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The insulin-like growth factor system and cancer</span></div><div class="casAuthors">LeRoith, Derek; Roberts, Charles T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-137</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The insulin-like growth factor (IGF) family of ligands, binding proteins and receptors is an important growth factor system involved in both the development of the organism and the maintenance of normal function of many cells of the body.  The system also has powerful anti-apoptotic effects.  More recently, evidence has accrued to demonstrate that the IGFs play an important role in cancer.  Individuals with serum IGF-II levels in the upper quartile of the normal range (and IGF binding protein-3 levels in the lower quartiles) have a relative risk for developing breast, prostate, colon and lung cancer.  IGF-II is commonly expressed by tumor cells and may act as an autocrine growth factor; occasionally even reaching target tissues and causing tumor-induced hypoglycemia.  The IGF-I receptor is commonly (though not always) overexpressed in many cancers, and many recent studies have identified new signaling pathways emanating from the IGF-I receptor that affect cancer cell proliferation, adhesion, migration and cell death; functions that are crit. for cancer cell survival and metastases.  In this review, many aspects of the IGF system and its relationship to cancer will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDripN7XEWorVg90H21EOLACvtfcHk0li0CHeKF22wQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFWmsrk%253D&md5=0515c75e9673e1e3ca6ce41f512a2e2f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0304-3835%2803%2900159-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3835%252803%252900159-9%26sid%3Dliteratum%253Aachs%26aulast%3DLeRoith%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DC.%2BT.%26atitle%3DThe%2520insulin-like%2520growth%2520factor%2520system%2520and%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2003%26volume%3D195%26spage%3D127%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Baserga, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peruzzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, K.</span><span> </span><span class="NLM_article-title">The IGF-1 receptor in cancer biology</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1002%2Fijc.11487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=14601044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFOgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2003&pages=873-877&author=R.+Basergaauthor=F.+Peruzziauthor=K.+Reiss&title=The+IGF-1+receptor+in+cancer+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The IGF-1 receptor in cancer biology</span></div><div class="casAuthors">Baserga, Renato; Peruzzi, Francesca; Reiss, Krysztof</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">873-877</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The type I insulin-like growth factor receptor (IGF-IR) plays an important role in the establishment and maintenance of the transformed phenotype.  It also has a strong antiapoptotic activity and has a significant influence on the control of cell and body size.  Downregulation of the IGF-IR leads to massive apoptosis of cancer cells.  These characteristics make it an attractive target for anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVej94ZLdT8LVg90H21EOLACvtfcHk0li0CHeKF22wQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFOgt7g%253D&md5=53aed4634fd9a52c0b3836a9c40991e0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fijc.11487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.11487%26sid%3Dliteratum%253Aachs%26aulast%3DBaserga%26aufirst%3DR.%26aulast%3DPeruzzi%26aufirst%3DF.%26aulast%3DReiss%26aufirst%3DK.%26atitle%3DThe%2520IGF-1%2520receptor%2520in%2520cancer%2520biology%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2003%26volume%3D107%26spage%3D873%26epage%3D877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohan, T.</span><span> </span><span class="NLM_article-title">J. Role of insulin-like growth factor family in cancer development and progression</span> <span class="citation_source-journal">Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">1472</span><span class="NLM_x">–</span> <span class="NLM_lpage">1489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1093%2Fjnci%2F92.18.1472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFKqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=1472-1489&issue=18&author=H.+Yuauthor=T.+Rohan&title=J.+Role+of+insulin-like+growth+factor+family+in+cancer+development+and+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the insulin-like growth factor family in cancer development and progression</span></div><div class="casAuthors">Yu, Herbert; Rohan, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1472-1489</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with ~ 316 refs.  The insulin-like growth factors (IGFs) are mitogens that play a pivotal role in regulating cell proliferation, differentiation, and apoptosis.  The effects of IGFs are mediated through the IGF-I receptor, which is also involved in cell transformation induced by tumor virus proteins and oncogene products.  Six IGF-binding proteins (IGFBPs) can inhibit or enhance the actions of IGFs.  These opposing effects are detd. by the structures of the binding proteins.  The effects of IGFBPs on IGFs are regulated in part by IGFBP proteases.  Lab. studies have shown that IGFs exert strong mitogenic and antiapoptotic actions on various cancer cells.  IGFs also act synergistically with other mitogenic growth factors and steroids and antagonize the effect of antiproliferative mols. on cancer growth.  The role of IGFs in cancer is supported by epidemiol. studies, which have found that high levels of circulating IGF-I and low levels of IGFBP-3 are assocd. with increased risk of several common cancers, including those of the prostate, breast, colorectum, and lung.  Evidence further suggests that certain lifestyles, such as one involving a high-energy diet, may increase IGF-I levels, a finding that is supported by animal expts. indicating that IGFs may abolish the inhibitory effect of energy restriction on cancer growth.  Further investigation of the role of IGFs in linking high energy intake, increased cell proliferation, suppression of apoptosis, and increased cancer risk may provide new insights into the etiol. of cancer and lead to new strategies for cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcx6kqz1pqXbVg90H21EOLACvtfcHk0li0CHeKF22wQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFKqsrw%253D&md5=f44af04e26bff771da45aafc7ccbeb98</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.18.1472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.18.1472%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DRohan%26aufirst%3DT.%26atitle%3DJ.%2520Role%2520of%2520insulin-like%2520growth%2520factor%2520family%2520in%2520cancer%2520development%2520and%2520progression%26jtitle%3DNatl.%2520Cancer%2520Inst.%26date%3D2000%26volume%3D92%26issue%3D18%26spage%3D1472%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">White, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogarty, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werther, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wraight, C. J.</span><span> </span><span class="NLM_article-title">Antisense inhibition of IGF-1 receptor expression in HaCaT keratinocytes: a model for antisense strategies in keratinocytes. Antisense</span> <span class="citation_source-journal">Nucleic Acid Drug Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=10905556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks12ju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=195-203&author=P.+J.+Whiteauthor=R.+D.+Fogartyauthor=G.+A.+Wertherauthor=C.+J.+Wraight&title=Antisense+inhibition+of+IGF-1+receptor+expression+in+HaCaT+keratinocytes%3A+a+model+for+antisense+strategies+in+keratinocytes.+Antisense"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antisense inhibition of IGF receptor expression in HaCaT keratinocytes: a model for antisense strategies in keratinocytes</span></div><div class="casAuthors">White, P. J.; Fogarty, R. D.; Werther, G. A.; Wraight, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Antisense & Nucleic Acid Drug Development</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">195-203</span>CODEN:
                <span class="NLM_cas:coden">ANADF5</span>;
        ISSN:<span class="NLM_cas:issn">1087-2906</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Antisense strategies targeting skin conditions are attractive in concept, with a no. of possible pathol. conditions, such a psoriasis, apparently suitable for such an approach.  Because in vitro screening of candidate sequences is usually desirable, we have attempted to use a range of new generation cationic lipids to produce significant antisense oligodeoxynucleotide (ODN) uptake in an immortalized keratinocyte cell line (HaCaT).  A large no. of com. available lipids were screened for the ability to induce nuclear ODN localization: Tfx-50, Tfx-20, Tfx-10, Superfect, Cytofectin GSV, Perfect lipids 1-8, Lipofectin, and Lipofectamine.  All lipids were used at a range of concns. (1-20 μg/mL) and with a range of ODN concns. (1-1000) nM.  Of all lipids used, only Cytofectin GSV and Superfect produced significant (>30% of cells) levels of nuclear pos. cells, with Superfect also producing significant toxicity at the effective concn. used.  Only two treatments produced a significant redn. in target mRNA: insulin-like growth factor-1 receptor (IGF-1R)-ODN 64 complexed with Cytofectin GSV (27.1% ± 3.5% of IGF-1R mRNA in untreated cells, p < 0.01) and ODN 64 complexed with 10 μg/mL Lipofectin (62.2% ± 3.4% of IGF-1R mRNA in untreated cells, p < 0.05).  Only one treatment, ODN 64 complexed with Cytofectin GSV, produced a redn. in cell growth and survival as assessed by amido black assay.  These results demonstrate that in HaCaT keratinocytes, Cytofectin GSV alone of all com. available cationic lipids was effective in delivering antisense ODN into cell nuclei such that a profound antisense effect could be demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq43trqbVcI_LVg90H21EOLACvtfcHk0libw8a1G1te2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks12ju7w%253D&md5=f267a6f32439b11d91c5b224d27fddc8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DP.%2BJ.%26aulast%3DFogarty%26aufirst%3DR.%2BD.%26aulast%3DWerther%26aufirst%3DG.%2BA.%26aulast%3DWraight%26aufirst%3DC.%2BJ.%26atitle%3DAntisense%2520inhibition%2520of%2520IGF-1%2520receptor%2520expression%2520in%2520HaCaT%2520keratinocytes%253A%2520a%2520model%2520for%2520antisense%2520strategies%2520in%2520keratinocytes.%2520Antisense%26jtitle%3DNucleic%2520Acid%2520Drug%2520Dev.%26date%3D2000%26volume%3D10%26spage%3D195%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">De Leon, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfield, R. G.</span><span> </span><span class="NLM_article-title">Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells</span> <span class="citation_source-journal">Growth Factors</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=327-336&author=D.+D.+De+Leonauthor=D.+M.+Wilsonauthor=M.+Powersauthor=R.+G.+Rosenfield&title=Effects+of+insulin-like+growth+factors+%28IGFs%29+and+IGF+receptor+antibodies+on+the+proliferation+of+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLeon%26aufirst%3DD.%2BD.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DPowers%26aufirst%3DM.%26aulast%3DRosenfield%26aufirst%3DR.%2BG.%26atitle%3DEffects%2520of%2520insulin-like%2520growth%2520factors%2520%2528IGFs%2529%2520and%2520IGF%2520receptor%2520antibodies%2520on%2520the%2520proliferation%2520of%2520human%2520breast%2520cancer%2520cells%26jtitle%3DGrowth%2520Factors%26date%3D1992%26volume%3D6%26spage%3D327%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Reiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Ambosio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baserga, R.</span><span> </span><span class="NLM_article-title">Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=9829727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADyaK1cXns1Ogtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=2647-2655&author=K.+Reissauthor=C.+D%E2%80%99Ambosioauthor=X.+Tuauthor=C.+Tuauthor=R.+Baserga&title=Inhibition+of+tumor+growth+by+a+dominant+negative+mutant+of+the+insulin-like+growth+factor+I+receptor+with+a+bystander+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect</span></div><div class="casAuthors">Reiss, Krzysztof; D'Ambrosio, Consuelo; Tu, Xiao; Tu, Chi; Baserga, Renato</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2647-2655</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The insulin-like growth factor I receptor is known to play a major role in transformation and apoptosis.  The dominant neg. mutant of the insulin-like growth factor I receptor, designated 486/STOP, causes massive apoptosis of tumor cells and inhibition of tumor growth and metastases.  We now show that: (a) the stable expression of 486/STOP inhibits transformation (colony formation in soft agar) and/or tumor growth in nude mice of five different types of human tumor cell lines; and (b) more importantly, it has a bystander effect, inhibiting the growth of wild-type tumor cells when cells expressing 486/STOP are coinjected with wild-type tumor cells.  These findings suggest that it is not necessary to infect all tumor cells with 486/STOP to inhibit tumor growth, and they also open the possibility of using the product of 486/STOP directly against tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC5Qzw9X_zP7Vg90H21EOLACvtfcHk0libw8a1G1te2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1Ogtb0%253D&md5=b03f84c833c15f57605bbaaf7d7b6668</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReiss%26aufirst%3DK.%26aulast%3DD%25E2%2580%2599Ambosio%26aufirst%3DC.%26aulast%3DTu%26aufirst%3DX.%26aulast%3DTu%26aufirst%3DC.%26aulast%3DBaserga%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520tumor%2520growth%2520by%2520a%2520dominant%2520negative%2520mutant%2520of%2520the%2520insulin-like%2520growth%2520factor%2520I%2520receptor%2520with%2520a%2520bystander%2520effect%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1998%26volume%3D4%26spage%3D2647%26epage%3D2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stampfer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannucci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gann, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennekesn, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollak, M.</span><span> </span><span class="NLM_article-title">Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study</span> <span class="citation_source-journal">Science (Washington, D.C.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1126%2Fscience.279.5350.563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=9438850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADyaK1cXotVOqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=563-566&author=J.+M.+Chanauthor=M.+J.+Stampferauthor=E.+Giovannucciauthor=P.+H.+Gannauthor=J.+Maauthor=P.+Wilkinsonauthor=C.+H.+Hennekesnauthor=M.+Pollak&title=Plasma+insulin-like+growth+factor-I+and+prostate+cancer+risk%3A+a+prospective+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study</span></div><div class="casAuthors">Chan, June M.; Stempfer, Meir J.; Giovannucci, Edward; Gann, Peter H.; Ma, Jing; Wilkinson, Peter; Hennekens, Charles H.; Pollak, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">5350</span>),
    <span class="NLM_cas:pages">563-566</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Insulin-like growth factor-I (IGF-I) is a mitogen for prostate epithelial cells.  To investigate assocns. between plasma IGF levels and prostate cancer risk, a nested case-control study within the Physicians' health Study was conducted on prospectively collected plasma from 152 cases and 152 controls.  A strong pos. assocn. was obsd. between IGF-I levels and prostate cancer risk.  Men in the highest quartile of IGF-I levels had a relative risk of 4.3 (95 % confidence interval 1.8 to 10.6) compared with men in the lowest quartile.  This assocn. was independent of baseline prostate-specific antigen levels.  Identification of plasma IGF-I as a predictor of prostate cancer risk may have implications for risk redn. and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN8T4rIgzxMLVg90H21EOLACvtfcHk0libw8a1G1te2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVOqsg%253D%253D&md5=43c076479c5fb946f61a42758043bd92</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.279.5350.563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.279.5350.563%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DJ.%2BM.%26aulast%3DStampfer%26aufirst%3DM.%2BJ.%26aulast%3DGiovannucci%26aufirst%3DE.%26aulast%3DGann%26aufirst%3DP.%2BH.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWilkinson%26aufirst%3DP.%26aulast%3DHennekesn%26aufirst%3DC.%2BH.%26aulast%3DPollak%26aufirst%3DM.%26atitle%3DPlasma%2520insulin-like%2520growth%2520factor-I%2520and%2520prostate%2520cancer%2520risk%253A%2520a%2520prospective%2520study%26jtitle%3DScience%2520%2528Washington%252C%2520D.C.%2529%26date%3D1998%26volume%3D279%26spage%3D563%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Wittman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balimane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eummer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frennesson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurlburt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnananthan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoeckler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span> </span><span class="NLM_article-title">Discovery of a (1<i>H</i>-benzimidazol-2-yl)-1<i>H</i>-pyridine-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5639</span><span class="NLM_x">–</span> <span class="NLM_lpage">5643</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050392q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5639-5643&author=M.+Wittmanauthor=J.+Carboniauthor=F.+Attarauthor=B.+Balasubramanianauthor=P.+Balimaneauthor=P.+Brassilauthor=F.+Beaulieuauthor=C.+Changauthor=W.+Clarkeauthor=J.+Dellauthor=J.+Eummerauthor=D.+Frennessonauthor=M.+Gottardisauthor=A.+Greerauthor=S.+Hanselauthor=W.+Hurlburtauthor=B.+Jacobsonauthor=S.+Krishnananthanauthor=F.+Y.+Leeauthor=A.+Liauthor=T.-A.+Linauthor=P.+Liuauthor=C.+Ouelletauthor=X.+Sangauthor=M.+G.+Saulnierauthor=K.+Stoffanauthor=Y.+Sunauthor=U.+Velaparthiauthor=D.+Vyasauthor=H.+Wongauthor=Z.+Yangauthor=K.+Zimmermannauthor=M.+Zoecklerauthor=D.+Vyas&title=Discovery+of+a+%281H-benzimidazol-2-yl%29-1H-pyridine-2-one+%28BMS-536924%29+inhibitor+of+insulin-like+growth+factor+I+receptor+kinase+with+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm050392q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050392q%26sid%3Dliteratum%253Aachs%26aulast%3DWittman%26aufirst%3DM.%26aulast%3DCarboni%26aufirst%3DJ.%26aulast%3DAttar%26aufirst%3DF.%26aulast%3DBalasubramanian%26aufirst%3DB.%26aulast%3DBalimane%26aufirst%3DP.%26aulast%3DBrassil%26aufirst%3DP.%26aulast%3DBeaulieu%26aufirst%3DF.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DClarke%26aufirst%3DW.%26aulast%3DDell%26aufirst%3DJ.%26aulast%3DEummer%26aufirst%3DJ.%26aulast%3DFrennesson%26aufirst%3DD.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DGreer%26aufirst%3DA.%26aulast%3DHansel%26aufirst%3DS.%26aulast%3DHurlburt%26aufirst%3DW.%26aulast%3DJacobson%26aufirst%3DB.%26aulast%3DKrishnananthan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DT.-A.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DOuellet%26aufirst%3DC.%26aulast%3DSang%26aufirst%3DX.%26aulast%3DSaulnier%26aufirst%3DM.%2BG.%26aulast%3DStoffan%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DVyas%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DZoeckler%26aufirst%3DM.%26aulast%3DVyas%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520%25281H-benzimidazol-2-yl%2529-1H-pyridine-2-one%2520%2528BMS-536924%2529%2520inhibitor%2520of%2520insulin-like%2520growth%2520factor%2520I%2520receptor%2520kinase%2520with%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5639%26epage%3D5643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references cited therein.</p></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ji, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld-Franklin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirritt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyzaguirre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachter, J. A.</span><span> </span><span class="NLM_article-title">A novel, potent, and selective insulin-like growth factor-1 receptor kinase inhibitor blocks insulin-like growth factor-1 receptor signaling in vitro and inhibits insulin-like growth factor-1 receptor dependent tumor growth in vivo</span> <span class="citation_source-journal">Mol. Cancer. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2158</span><span class="NLM_x">–</span> <span class="NLM_lpage">2167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1158%2F1535-7163.MCT-07-0070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=17671083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVGltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2158-2167&issue=8&author=Q.-S.+Jiauthor=M.+Mulvihillauthor=M.+Rosenfeld-Franklinauthor=A.+Cookeauthor=L.+Fengauthor=G.+Makauthor=M.+O%E2%80%99Connorauthor=Y.+Yaoauthor=C.+Pirrittauthor=E.+Buckauthor=A.+Eyzaguirreauthor=L.+D.+Arnoldauthor=N.+W.+Gibsonauthor=J.+A.+Pachter&title=A+novel%2C+potent%2C+and+selective+insulin-like+growth+factor-1+receptor+kinase+inhibitor+blocks+insulin-like+growth+factor-1+receptor+signaling+in+vitro+and+inhibits+insulin-like+growth+factor-1+receptor+dependent+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor-dependent tumor growth in vivo</span></div><div class="casAuthors">Ji, Qun-sheng; Mulvihill, Mark J.; Rosenfeld-Franklin, Maryland; Cooke, Andrew; Feng, Lixin; Mak, Gilda; O'Connor, Matthew; Yao, Yan; Pirritt, Caroline; Buck, Elizabeth; Eyzaguirre, Alexandra; Arnold, Lee D.; Gibson, Neil W.; Pachter, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2158-2167</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Insulin-like growth factor-I receptor (IGF-IR) and its ligands, IGF-I and IGF-II, are up-regulated in a variety of human cancers.  In tumors, such as colorectal, non-small cell lung, ovarian, and pediatric cancers, which may drive their own growth and survival through autocrine IGF-II expression, the role of IGF-IR is esp. crit.  Here, we present a novel small-mol. IGF-IR kinase inhibitor, cis-3-[3-(4-methyl-piperazin-l-yl)-cyclobutyl]-1-(2-phenyl-quinolin-7-yl)-imidazo[1,5-a]pyrazin-8-ylamine (PQIP), which displayed a cellular IC50 of 19 nmol/L for inhibition of ligand-dependent autophosphorylation of human IGF-IR with 14-fold cellular selectivity relative to the human insulin receptor.  PQIP showed minimal activity against a panel of 32 other protein kinases.  It also abolished the ligand-induced activation of downstream phosphorylated AKT and phosphorylated extracellular signal-regulated kinase 1/2 in both IGF-IR transfectant cells and a GEO human colorectal cancer cell line.  Anal. of GEO cells revealed a significant level of both phosphorylated IGF-IR and IGF-II expression.  Furthermore, inactivation of IGF-II in conditioned GEO culture medium by a neutralizing antibody diminished IGF-IR activation, indicating the presence of a functional IGF-II/IGF-IR autocrine loop in GEO cells.  Once daily oral dosing of PQIP induced robust antitumor efficacy in GEO xenografts.  The antitumor efficacy correlated with the degree and duration of inhibition of tumor IGF-IR phosphorylation in vivo by this compd.  Moreover, when mice were treated for 3 days with a dose of PQIP that maximally inhibited tumor growth, only minor changes in blood glucose were obsd.  Thus, PQIP represents a potent and selective IGF-IR kinase inhibitor that is esp. efficacious in an IGF-II-driven human tumor model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUljsbsd3CzbVg90H21EOLACvtfcHk0litIaupcVZUzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVGltLg%253D&md5=d0d7c5cb6b4ec09893b3ff178f4613d7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0070%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DQ.-S.%26aulast%3DMulvihill%26aufirst%3DM.%26aulast%3DRosenfeld-Franklin%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DPirritt%26aufirst%3DC.%26aulast%3DBuck%26aufirst%3DE.%26aulast%3DEyzaguirre%26aufirst%3DA.%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26aulast%3DPachter%26aufirst%3DJ.%2BA.%26atitle%3DA%2520novel%252C%2520potent%252C%2520and%2520selective%2520insulin-like%2520growth%2520factor-1%2520receptor%2520kinase%2520inhibitor%2520blocks%2520insulin-like%2520growth%2520factor-1%2520receptor%2520signaling%2520in%2520vitro%2520and%2520inhibits%2520insulin-like%2520growth%2520factor-1%2520receptor%2520dependent%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DMol.%2520Cancer.%2520Ther.%26date%3D2007%26volume%3D6%26issue%3D8%26spage%3D2158%26epage%3D2167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Haluska, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loegering, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frennesson, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalli, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conover, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlichman, C.</span><span> </span><span class="NLM_article-title">In vitro and in vivo antitumor effects of dual insulin-like growth factor-1/insulin receptor inhibitor, BMS-554417</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=362-371&author=P.+Haluskaauthor=J.+M.+Carboniauthor=D.+A.+Loegeringauthor=F.+Y.+Leeauthor=M.+Wittmanauthor=M.+G.+Saulnierauthor=D.+B.+Frennessonauthor=D.+A.+Kalliauthor=C.+A.+Conoverauthor=R.+M.+Attarauthor=S.+H.+Kaufmannauthor=M.+Gottardisauthor=C.+Erlichman&title=In+vitro+and+in+vivo+antitumor+effects+of+dual+insulin-like+growth+factor-1%2Finsulin+receptor+inhibitor%2C+BMS-554417"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaluska%26aufirst%3DP.%26aulast%3DCarboni%26aufirst%3DJ.%2BM.%26aulast%3DLoegering%26aufirst%3DD.%2BA.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DWittman%26aufirst%3DM.%26aulast%3DSaulnier%26aufirst%3DM.%2BG.%26aulast%3DFrennesson%26aufirst%3DD.%2BB.%26aulast%3DKalli%26aufirst%3DD.%2BA.%26aulast%3DConover%26aufirst%3DC.%2BA.%26aulast%3DAttar%26aufirst%3DR.%2BM.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DErlichman%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520effects%2520of%2520dual%2520insulin-like%2520growth%2520factor-1%252Finsulin%2520receptor%2520inhibitor%252C%2520BMS-554417%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D362%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoeckler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span> </span><span class="NLM_article-title">Imidazole moiety replacements in the 3-(1<i>H</i>-benzo[<i>d</i>]imidazole-2-yl)pyridine-2(1<i>H</i>)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3072</span><span class="NLM_x">–</span> <span class="NLM_lpage">3076</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3072-3076&author=U.+Velaparthiauthor=P.+Liuauthor=B.+Balasubramanianauthor=J.+Carboniauthor=R.+Attarauthor=M.+Gottardisauthor=A.+Liauthor=A.+Greerauthor=M.+Zoecklerauthor=M.+D.+Wittmanauthor=D.+Vyas&title=Imidazole+moiety+replacements+in+the+3-%281H-benzo%5Bd%5Dimidazole-2-yl%29pyridine-2%281H%29-one+inhibitors+of+insulin-like+growth+factor+receptor-1+%28IGF-1R%29+to+improve+cytochrome+P450+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DB.%26aulast%3DCarboni%26aufirst%3DJ.%26aulast%3DAttar%26aufirst%3DR.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DGreer%26aufirst%3DA.%26aulast%3DZoeckler%26aufirst%3DM.%26aulast%3DWittman%26aufirst%3DM.%2BD.%26aulast%3DVyas%26aufirst%3DD.%26atitle%3DImidazole%2520moiety%2520replacements%2520in%2520the%25203-%25281H-benzo%255Bd%255Dimidazole-2-yl%2529pyridine-2%25281H%2529-one%2520inhibitors%2520of%2520insulin-like%2520growth%2520factor%2520receptor-1%2520%2528IGF-1R%2529%2520to%2520improve%2520cytochrome%2520P450%2520profile%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3072%26epage%3D3076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span> </span><span class="NLM_article-title">Discovery and initial SAR of 3-(1<i>H</i>-benzo[<i>d</i>]imidazole-2-yl)pyridine-2(1<i>H</i>)-ones as inhibitors of insulin-like growth factor-1 recpetor (IGF-1R)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2317</span><span class="NLM_x">–</span> <span class="NLM_lpage">2321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2317-2321&author=U.+Velaparthiauthor=M.+Wittmanauthor=P.+Liuauthor=K.+Stoffanauthor=K.+Zimmermannauthor=X.+Sangauthor=J.+Carboniauthor=A.+Liauthor=R.+Attarauthor=M.+Gottardisauthor=A.+Greerauthor=C.+Y.+Changauthor=B.+L.+Jacobsenauthor=J.+S.+Sackauthor=Y.+Sunauthor=D.+R.+Langleyauthor=B.+Balasubramanianauthor=D.+Vyas&title=Discovery+and+initial+SAR+of+3-%281H-benzo%5Bd%5Dimidazole-2-yl%29pyridine-2%281H%29-ones+as+inhibitors+of+insulin-like+growth+factor-1+recpetor+%28IGF-1R%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DWittman%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DStoffan%26aufirst%3DK.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DSang%26aufirst%3DX.%26aulast%3DCarboni%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DAttar%26aufirst%3DR.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DGreer%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DJacobsen%26aufirst%3DB.%2BL.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DBalasubramanian%26aufirst%3DB.%26aulast%3DVyas%26aufirst%3DD.%26atitle%3DDiscovery%2520and%2520initial%2520SAR%2520of%25203-%25281H-benzo%255Bd%255Dimidazole-2-yl%2529pyridine-2%25281H%2529-ones%2520as%2520inhibitors%2520of%2520insulin-like%2520growth%2520factor-1%2520recpetor%2520%2528IGF-1R%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2317%26epage%3D2321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wittman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoeckler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span> </span><span class="NLM_article-title">Novel 1<i>H</i>-(benzoimidazole-2-yl)-1<i>H</i>-pyridine-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">974</span><span class="NLM_x">–</span> <span class="NLM_lpage">977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=974-977&author=M.+D.+Wittmanauthor=B.+Balasubramanianauthor=K.+Stoffanauthor=U.+Velaparthiauthor=P.+Liuauthor=S.+Krishnanathanauthor=J.+Carboniauthor=A.+Liauthor=A.+Greerauthor=R.+Attarauthor=M.+Gottardisauthor=C.+Changauthor=B.+Jacobsonauthor=Y.+Sunauthor=S.+Hanselauthor=M.+Zoecklerauthor=D.+Vyas&title=Novel+1H-%28benzoimidazole-2-yl%29-1H-pyridine-2-one+inhibitors+of+insulin-like+growth+factor+I+%28IGF-1R%29+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWittman%26aufirst%3DM.%2BD.%26aulast%3DBalasubramanian%26aufirst%3DB.%26aulast%3DStoffan%26aufirst%3DK.%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DKrishnanathan%26aufirst%3DS.%26aulast%3DCarboni%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DGreer%26aufirst%3DA.%26aulast%3DAttar%26aufirst%3DR.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DHansel%26aufirst%3DS.%26aulast%3DZoeckler%26aufirst%3DM.%26aulast%3DVyas%26aufirst%3DD.%26atitle%3DNovel%25201H-%2528benzoimidazole-2-yl%2529-1H-pyridine-2-one%2520inhibitors%2520of%2520insulin-like%2520growth%2520factor%2520I%2520%2528IGF-1R%2529%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D974%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesario, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saroglou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolz, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sujka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkes, R.</span><span> </span><span class="NLM_article-title">1,3-Disubstitued imidazol[1,5-<i>a</i>]pyrazines as insulin-like growth factor-I receptor (IGF-IR) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1091-1097&issue=4&author=M.+J.+Mulvihillauthor=Q.-S.+Jiauthor=D.+Wernerauthor=P.+Beckauthor=C.+Cesarioauthor=A.+Cookeauthor=M.+Coxauthor=A.+Crewauthor=H.+Dongauthor=L.+Fengauthor=K.+W.+Foremanauthor=G.+Makauthor=A.+Nigroauthor=M.+O%E2%80%99Connorauthor=L.+Saroglouauthor=K.+M.+Stolzauthor=I.+Sujkaauthor=B.+Volkauthor=Q.+Wengauthor=R.+Wilkes&title=1%2C3-Disubstitued+imidazol%5B1%2C5-a%5Dpyrazines+as+insulin-like+growth+factor-I+receptor+%28IGF-IR%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26aulast%3DJi%26aufirst%3DQ.-S.%26aulast%3DWerner%26aufirst%3DD.%26aulast%3DBeck%26aufirst%3DP.%26aulast%3DCesario%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DM.%26aulast%3DCrew%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DForeman%26aufirst%3DK.%2BW.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DNigro%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%26aulast%3DSaroglou%26aufirst%3DL.%26aulast%3DStolz%26aufirst%3DK.%2BM.%26aulast%3DSujka%26aufirst%3DI.%26aulast%3DVolk%26aufirst%3DB.%26aulast%3DWeng%26aufirst%3DQ.%26aulast%3DWilkes%26aufirst%3DR.%26atitle%3D1%252C3-Disubstitued%2520imidazol%255B1%252C5-a%255Dpyrazines%2520as%2520insulin-like%2520growth%2520factor-I%2520receptor%2520%2528IGF-IR%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D4%26spage%3D1091%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hubbard, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamaung, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilsbacher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, G. S.</span><span> </span><span class="NLM_article-title">Pyrazolo[3,4-<i>d</i>]pyridimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5406</span><span class="NLM_x">–</span> <span class="NLM_lpage">5409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5406-5409&author=R.+D.+Hubbardauthor=N.+Y.+Bamaungauthor=F.+Palazzoauthor=Q.+Zhangauthor=P.+Kovarauthor=D.+J.+Osterlingauthor=X.+Huauthor=J.+L.+Wilsbacherauthor=E.+F.+Johnsonauthor=J.+Bouskaauthor=J.+Wangauthor=R.+L.+Bellauthor=S.+K.+Davidsenauthor=G.+S.+Sheppard&title=Pyrazolo%5B3%2C4-d%5Dpyridimidines+as+potent+inhibitors+of+the+insulin-like+growth+factor+receptor+%28IGF-IR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DR.%2BD.%26aulast%3DBamaung%26aufirst%3DN.%2BY.%26aulast%3DPalazzo%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DWilsbacher%26aufirst%3DJ.%2BL.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DBouska%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBell%26aufirst%3DR.%2BL.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26atitle%3DPyrazolo%255B3%252C4-d%255Dpyridimidines%2520as%2520potent%2520inhibitors%2520of%2520the%2520insulin-like%2520growth%2520factor%2520receptor%2520%2528IGF-IR%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5406%26epage%3D5409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><div class="note"><p class="first last">Recently OSI Pharmaceuticals and Exlexis have reported that their IGF-1R inhibitors, OSI-906 and XL-228, respectively, entered phase I clinical trials</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Recently+OSI+Pharmaceuticals+and+Exlexis+have+reported+that+their+IGF-1R+inhibitors%2C+OSI-906+and+XL-228%2C+respectively%2C+entered+phase+I+clinical+trials."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moore, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliewer, S. A.</span><span> </span><span class="NLM_article-title">Use of the nuclear receptor PXR to preedict drug interactions</span> <span class="citation_source-journal">Toxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2003&pages=1-10&author=J.+T.+Mooreauthor=S.+A.+Kliewer&title=Use+of+the+nuclear+receptor+PXR+to+preedict+drug+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DJ.%2BT.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26atitle%3DUse%2520of%2520the%2520nuclear%2520receptor%2520PXR%2520to%2520preedict%2520drug%2520interactions%26jtitle%3DToxicology%26date%3D2003%26volume%3D153%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gao, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkovec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span> </span><span class="NLM_article-title">Attenuating pregnane X receptor (PXR) activation: A molecular modelling approach</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1080%2F00498250601050412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=17484516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1ChsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=124-138&issue=2&author=Y.+D.+Gaoauthor=S.+H.+Olsonauthor=J.+M.+Balkovecauthor=Y.+Zhuauthor=I.+Royoauthor=J.+Yabutauthor=R.+Eversauthor=E.+Y.+Tanauthor=W.+Tangauthor=D.+P.+Hartleyauthor=R.+T.+Mosley&title=Attenuating+pregnane+X+receptor+%28PXR%29+activation%3A+A+molecular+modelling+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuating pregnane X receptor (PXR) activation: a molecular modelling approach</span></div><div class="casAuthors">Gao, Y.-D.; Olson, S. H.; Balkovec, J. M.; Zhu, Y.; Royo, I.; Yabut, J.; Evers, R.; Tan, E. Y.; Tang, W.; Hartley, D. P.; Mosley, R. T.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-138</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Recent studies have demonstrated that the pregnane X receptor (PXR) is a key regulator of cytochromes P 450 3A (e.g. CYP3A4 in human) gene expression.  As a result, activation of PXR may lead to CYP3A4 protein over-expression.  Because induction of CYP3A4 could result in clin. important drug-drug interactions, there has been a great interest in reducing the possibility of PXR activation by drug candidates in drug-discovery programs.  In order to provide structural insight for attenuating drug candidate-mediated PXR activation, we used a docking approach to study the structure-activity relationship for PXR activators.  Based on our docking models, it is proposed that introducing polar groups to the end of an activator should reduce its human PXR (hPXR) activity via destabilizing interactions in the hydrophobic areas of the PXR ligand-binding pocket.  A no. of analogs that incorporate these structural features then were designed and synthesized, and they exhibited significantly lower hPXR activation in a transactivation assay and decreased CYP3A4 induction in a human hepatocytes-based assay.  In addn., an example in which attenuating hPXR activation was achieved by sterically destabilizing the helixes 11 and 12 of the receptor is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBZSC0secQoLVg90H21EOLACvtfcHk0liVKWAPBJA6rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1ChsrY%253D&md5=400688510dd165a4a9632b6ba10bf267</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1080%2F00498250601050412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250601050412%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%2BD.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DBalkovec%26aufirst%3DJ.%2BM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DRoyo%26aufirst%3DI.%26aulast%3DYabut%26aufirst%3DJ.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DE.%2BY.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26atitle%3DAttenuating%2520pregnane%2520X%2520receptor%2520%2528PXR%2529%2520activation%253A%2520A%2520molecular%2520modelling%2520approach%26jtitle%3DXenobiotica%26date%3D2007%26volume%3D37%26issue%3D2%26spage%3D124%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Carboni, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadsell, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bol, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camuso, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurlburt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westhouse, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupnow, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, T. W.</span><span> </span><span class="NLM_article-title">Tumor development by transgenic expression of a constitutively active insulin-like growth factor-1 receptor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">–</span> <span class="NLM_lpage">3787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=3781-3787&author=J.+M.+Carboniauthor=A.+V.+Leeauthor=D.+L.+Hadsellauthor=B.+R.+Rowleyauthor=F.+Y.+Leeauthor=D.+K.+Bolauthor=A.+E.+Camusoauthor=M.+Gottardisauthor=A.+F.+Greerauthor=C.+P.+Hoauthor=W.+Hurlburtauthor=A.+Liauthor=M.+G.+Saulnierauthor=U.+Velaparthiauthor=C.+Wangauthor=M.-L.+Wenauthor=R.+A.+Westhouseauthor=M.+Wittmanauthor=K.+Zimmermannauthor=B.+A.+Rupnowauthor=T.+W.+Wong&title=Tumor+development+by+transgenic+expression+of+a+constitutively+active+insulin-like+growth+factor-1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarboni%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DA.%2BV.%26aulast%3DHadsell%26aufirst%3DD.%2BL.%26aulast%3DRowley%26aufirst%3DB.%2BR.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DBol%26aufirst%3DD.%2BK.%26aulast%3DCamuso%26aufirst%3DA.%2BE.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DGreer%26aufirst%3DA.%2BF.%26aulast%3DHo%26aufirst%3DC.%2BP.%26aulast%3DHurlburt%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DSaulnier%26aufirst%3DM.%2BG.%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DM.-L.%26aulast%3DWesthouse%26aufirst%3DR.%2BA.%26aulast%3DWittman%26aufirst%3DM.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DRupnow%26aufirst%3DB.%2BA.%26aulast%3DWong%26aufirst%3DT.%2BW.%26atitle%3DTumor%2520development%2520by%2520transgenic%2520expression%2520of%2520a%2520constitutively%2520active%2520insulin-like%2520growth%2520factor-1%2520receptor%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D3781%26epage%3D3787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wittman, D. M. B.; Balasubramanian, N.; Velaparthi, U.; Zimmermann, K.; Saulnier, G. M.; Liu, P.; Sang, X.; Frennesson, B. D.; Stoffan, K. M.; Tarrant, J.; Marinier, A.; Roy, S.</span><span> </span><span class="NLM_article-title">Preparation of 2-(4-substituted-2-oxo-1,2-dihydropyridine-3-yl)-benzimidazoles as novel tyrosine kinase inhibitors</span>. U.S. Patent US2004/044203 A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=D.+M.+B.+Wittman&author=N.+Balasubramanian&author=U.+Velaparthi&author=K.+Zimmermann&author=G.+M.+Saulnier&author=P.+Liu&author=X.+Sang&author=B.+D.+Frennesson&author=K.+M.+Stoffan&author=J.+Tarrant&author=A.+Marinier&author=S.+Roy&title=Preparation+of+2-%284-substituted-2-oxo-1%2C2-dihydropyridine-3-yl%29-benzimidazoles+as+novel+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWittman%26aufirst%3DD.%2BM.%2BB.%26atitle%3DPreparation%2520of%25202-%25284-substituted-2-oxo-1%252C2-dihydropyridine-3-yl%2529-benzimidazoles%2520as%2520novel%2520tyrosine%2520kinase%2520inhibitors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Saulnier, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frennessn, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struzynski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balimane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span> </span><span class="NLM_article-title">2-(1<i>H</i>-Imidazol-4-yl)ethanamine and 2-(1<i>H</i>-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1702</span><span class="NLM_x">–</span> <span class="NLM_lpage">1707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1702-1707&author=M.+G.+Saulnierauthor=D.+B.+Frennessnauthor=M.+D.+Wittmanauthor=K.+Zimmermannauthor=U.+Velaparthiauthor=D.+R.+Langleyauthor=C.+Struzynskiauthor=X.+Sangauthor=J.+Carboniauthor=A.+Liauthor=A.+Greerauthor=Z.+Yangauthor=P.+Balimaneauthor=M.+Gottardisauthor=M.+Attarauthor=D.+Vyas&title=2-%281H-Imidazol-4-yl%29ethanamine+and+2-%281H-pyrazol-1-yl%29ethanamine+side+chain+variants+of+the+IGF-1R+inhibitor+BMS-536924"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaulnier%26aufirst%3DM.%2BG.%26aulast%3DFrennessn%26aufirst%3DD.%2BB.%26aulast%3DWittman%26aufirst%3DM.%2BD.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DStruzynski%26aufirst%3DC.%26aulast%3DSang%26aufirst%3DX.%26aulast%3DCarboni%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DGreer%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DBalimane%26aufirst%3DP.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DAttar%26aufirst%3DM.%26aulast%3DVyas%26aufirst%3DD.%26atitle%3D2-%25281H-Imidazol-4-yl%2529ethanamine%2520and%25202-%25281H-pyrazol-1-yl%2529ethanamine%2520side%2520chain%2520variants%2520of%2520the%2520IGF-1R%2520inhibitor%2520BMS-536924%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1702%26epage%3D1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">The potential disruption of glucose homeostasis by compound <b>10</b> arising from the inhibition of IR was evaluated in vivo in oral glucose tolerance test (OGTT). The test was performed in mice at both 50 and 100 mpk and found that significant glucose elevation was not observed prior to glucose challenge. However, after glucose challenge, an elevation of glucose level is observed at the 100 mpk dose that is very similar to the effect observed for compound <b>1</b> as reported in reference <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+potential+disruption+of+glucose+homeostasis+by+compound+10+arising+from+the+inhibition+of+IR+was+evaluated+in+vivo+in+oral+glucose+tolerance+test+%28OGTT%29.+The+test+was+performed+in+mice+at+both+50+and+100+mpk+and+found+that+significant+glucose+elevation+was+not+observed+prior+to+glucose+challenge.+However%2C+after+glucose+challenge%2C+an+elevation+of+glucose+level+is+observed+at+the+100+mpk+dose+that+is+very+similar+to+the+effect+observed+for+compound+1+as+reported+in+reference+10."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Adrian Hall, Hugues Chanteux, Karelle Ménochet, Marie Ledecq, <span class="NLM_string-name hlFld-ContribAuthor">Monika-Sarah E. D. Schulze</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6413-6522. <a href="https://doi.org/10.1021/acs.jmedchem.0c02245" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02245%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252BOut%252BPXR%252BActivity%252Bon%252BDrug%252BDiscovery%252BProjects%25253A%252BA%252BReview%252Bof%252BStructure-Based%252BMethods%25252C%252BEmpirical%252Band%252BComputational%252BApproaches%26aulast%3DHall%26aufirst%3DAdrian%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D27122020%26date%3D18052021%26volume%3D64%26issue%3D10%26spage%3D6413%26epage%3D6522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex D.  Martin</span>, <span class="hlFld-ContribAuthor ">Ali R.  Siamaki</span>, <span class="hlFld-ContribAuthor ">Katherine  Belecki</span>, and <span class="hlFld-ContribAuthor ">B. Frank  Gupton</span>  . </span><span class="cited-content_cbyCitation_article-title">A Convergent Approach to the Total Synthesis of Telmisartan via a Suzuki Cross-Coupling Reaction between Two Functionalized Benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (3)
                                     , 1915-1919. <a href="https://doi.org/10.1021/jo5025333" title="DOI URL">https://doi.org/10.1021/jo5025333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo5025333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo5025333%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BConvergent%252BApproach%252Bto%252Bthe%252BTotal%252BSynthesis%252Bof%252BTelmisartan%252Bvia%252Ba%252BSuzuki%252BCross-Coupling%252BReaction%252Bbetween%252BTwo%252BFunctionalized%252BBenzimidazoles%26aulast%3DMartin%26aufirst%3DAlex%2BD.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05112014%26date%3D12012015%26date%3D06022015%26date%3D18122014%26volume%3D80%26issue%3D3%26spage%3D1915%26epage%3D1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suvi T. M.  Orr</span>, <span class="hlFld-ContribAuthor ">Sharon L.  Ripp</span>, <span class="hlFld-ContribAuthor ">T. Eric  Ballard</span>, <span class="hlFld-ContribAuthor ">Jaclyn L.  Henderson</span>, <span class="hlFld-ContribAuthor ">Dennis O.  Scott</span>, <span class="hlFld-ContribAuthor ">R. Scott  Obach</span>, <span class="hlFld-ContribAuthor ">Hao  Sun</span>, and <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>  . </span><span class="cited-content_cbyCitation_article-title">Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure–Activity Relationships and Discovery Strategies To Mitigate Drug–Drug Interaction Risks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (11)
                                     , 4896-4933. <a href="https://doi.org/10.1021/jm300065h" title="DOI URL">https://doi.org/10.1021/jm300065h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300065h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300065h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMechanism-Based%252BInactivation%252B%252528MBI%252529%252Bof%252BCytochrome%252BP450%252BEnzymes%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BDiscovery%252BStrategies%252BTo%252BMitigate%252BDrug%2525E2%252580%252593Drug%252BInteraction%252BRisks%26aulast%3DOrr%26aufirst%3DSuvi%2BT.%2BM.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D15012012%26date%3D27032012%26date%3D14062012%26date%3D12032012%26volume%3D55%26issue%3D11%26spage%3D4896%26epage%3D4933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alfonso T.  García-Sosa</span>, <span class="hlFld-ContribAuthor ">Sulev  Sild</span>, <span class="hlFld-ContribAuthor ">Kalev  Takkis</span>, and <span class="hlFld-ContribAuthor ">Uko  Maran</span>  . </span><span class="cited-content_cbyCitation_article-title">Combined Approach Using Ligand Efficiency, Cross-Docking, and Antitarget Hits for Wild-Type and Drug-Resistant Y181C HIV-1 Reverse Transcriptase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (10)
                                     , 2595-2611. <a href="https://doi.org/10.1021/ci200203h" title="DOI URL">https://doi.org/10.1021/ci200203h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci200203h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci200203h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DCombined%252BApproach%252BUsing%252BLigand%252BEfficiency%25252C%252BCross-Docking%25252C%252Band%252BAntitarget%252BHits%252Bfor%252BWild-Type%252Band%252BDrug-Resistant%252BY181C%252BHIV-1%252BReverse%252BTranscriptase%26aulast%3DGarc%25C3%25ADa-Sosa%26aufirst%3DAlfonso%2BT.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D06052011%26date%3D15092011%26date%3D24102011%26date%3D30082011%26volume%3D51%26issue%3D10%26spage%3D2595%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rongshi  Li</span>, <span class="hlFld-ContribAuthor ">Alan  Pourpak</span> and <span class="hlFld-ContribAuthor ">Stephan W.  Morris</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibition of the Insulin-like Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (16)
                                     , 4981-5004. <a href="https://doi.org/10.1021/jm9002395" title="DOI URL">https://doi.org/10.1021/jm9002395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9002395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9002395%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252Bthe%252BInsulin-like%252BGrowth%252BFactor-1%252BReceptor%252B%252528IGF1R%252529%252BTyrosine%252BKinase%252Bas%252Ba%252BNovel%252BCancer%252BTherapy%252BApproach%26aulast%3DLi%26aufirst%3DRongshi%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D24022009%26date%3D17072009%26date%3D27082009%26volume%3D52%26issue%3D16%26spage%3D4981%26epage%3D5004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun  Zhang</span>, <span class="hlFld-ContribAuthor ">Andrew  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridones in drug discovery: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>38 </em>, 127849. <a href="https://doi.org/10.1016/j.bmcl.2021.127849" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127849%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyridones%252Bin%252Bdrug%252Bdiscovery%25253A%252BRecent%252Badvances%26aulast%3DZhang%26aufirst%3DYun%26date%3D2021%26volume%3D38%26spage%3D127849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir  Simov</span>, <span class="hlFld-ContribAuthor ">Sujal V.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Dinsmore</span>, <span class="hlFld-ContribAuthor ">Fiona  Elwood</span>, <span class="hlFld-ContribAuthor ">Rafael B.  Fernandez</span>, <span class="hlFld-ContribAuthor ">Yudith  Garcia</span>, <span class="hlFld-ContribAuthor ">Craig  Gibeau</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Joon  Jung</span>, <span class="hlFld-ContribAuthor ">Jason D.  Katz</span>, <span class="hlFld-ContribAuthor ">Brian  Kraybill</span>, <span class="hlFld-ContribAuthor ">Blair  Lapointe</span>, <span class="hlFld-ContribAuthor ">Sangita B.  Patel</span>, <span class="hlFld-ContribAuthor ">Tony  Siu</span>, <span class="hlFld-ContribAuthor ">Hua  Su</span>, <span class="hlFld-ContribAuthor ">Jonathan R.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design and development of (benz)imidazole pyridones as JAK1-selective kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (7)
                                     , 1803-1808. <a href="https://doi.org/10.1016/j.bmcl.2016.02.035" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.02.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.02.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%252Band%252Bdevelopment%252Bof%252B%252528benz%252529imidazole%252Bpyridones%252Bas%252BJAK1-selective%252Bkinase%252Binhibitors%26aulast%3DSimov%26aufirst%3DVladimir%26date%3D2016%26volume%3D26%26issue%3D7%26spage%3D1803%26epage%3D1808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kasia  Kieltyka</span>, <span class="hlFld-ContribAuthor ">Brian  McAuliffe</span>, <span class="hlFld-ContribAuthor ">Christopher  Cianci</span>, <span class="hlFld-ContribAuthor ">Dieter M.  Drexler</span>, <span class="hlFld-ContribAuthor ">Wilson  Shou</span>, <span class="hlFld-ContribAuthor ">Jun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Cassette Ultracentrifugation Using Non-labeled Compounds and Liquid Chromatography-Tandem Mass Spectrometry Analysis for High-Throughput Protein Binding Determination. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Sciences</span><span> <strong>2016,</strong> <em>105 </em>
                                    (3)
                                     , 1036-1042. <a href="https://doi.org/10.1016/S0022-3549(15)00177-X" title="DOI URL">https://doi.org/10.1016/S0022-3549(15)00177-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0022-3549(15)00177-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0022-3549%2815%2900177-X%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DApplication%252Bof%252BCassette%252BUltracentrifugation%252BUsing%252BNon-labeled%252BCompounds%252Band%252BLiquid%252BChromatography-Tandem%252BMass%252BSpectrometry%252BAnalysis%252Bfor%252BHigh-Throughput%252BProtein%252BBinding%252BDetermination%26aulast%3DKieltyka%26aufirst%3DKasia%26date%3D2016%26volume%3D105%26issue%3D3%26spage%3D1036%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangappa S.  Keri</span>, <span class="hlFld-ContribAuthor ">Asha  Hiremathad</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Budagumpi</span>, <span class="hlFld-ContribAuthor ">Bhari Mallanna  Nagaraja</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive Review in Current Developments of Benzimidazole-Based Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (1)
                                     , 19-65. <a href="https://doi.org/10.1111/cbdd.12462" title="DOI URL">https://doi.org/10.1111/cbdd.12462</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12462%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DComprehensive%252BReview%252Bin%252BCurrent%252BDevelopments%252Bof%252BBenzimidazole-Based%252BMedicinal%252BChemistry%26aulast%3DKeri%26aufirst%3DRangappa%2BS.%26date%3D2015%26date%3D2014%26volume%3D86%26issue%3D1%26spage%3D19%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Xue-Cheng  Liu</span>, <span class="hlFld-ContribAuthor ">Zhi-Bin  Huang</span>, <span class="hlFld-ContribAuthor ">Da-Qing  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed Cyclization of 3-Acylcoumarin Hydrazone using Air as the Oxidant: Efficient Synthesis of Pyrazole-Fused Coumarin Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2015,</strong> <em>52 </em>
                                    (2)
                                     , 380-385. <a href="https://doi.org/10.1002/jhet.2052" title="DOI URL">https://doi.org/10.1002/jhet.2052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2052%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DCopper-catalyzed%252BCyclization%252Bof%252B3-Acylcoumarin%252BHydrazone%252Busing%252BAir%252Bas%252Bthe%252BOxidant%25253A%252BEfficient%252BSynthesis%252Bof%252BPyrazole-Fused%252BCoumarin%252BDerivatives%26aulast%3DWang%26aufirst%3DHui-Yan%26date%3D2015%26date%3D2014%26volume%3D52%26issue%3D2%26spage%3D380%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valmik  Aware</span>, <span class="hlFld-ContribAuthor ">Nitin  Gaikwad</span>, <span class="hlFld-ContribAuthor ">Sambhaji  Chavan</span>, <span class="hlFld-ContribAuthor ">Sonal  Manohar</span>, <span class="hlFld-ContribAuthor ">Julie  Bose</span>, <span class="hlFld-ContribAuthor ">Smriti  Khanna</span>, <span class="hlFld-ContribAuthor ">Chandrika  B-Rao</span>, <span class="hlFld-ContribAuthor ">Neeta  Dixit</span>, <span class="hlFld-ContribAuthor ">Kishori Sharan  Singh</span>, <span class="hlFld-ContribAuthor ">Anagha  Damre</span>, <span class="hlFld-ContribAuthor ">Rajiv  Sharma</span>, <span class="hlFld-ContribAuthor ">Sambhaji  Patil</span>, <span class="hlFld-ContribAuthor ">Abhijit  Roychowdhury</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclopentyl-pyrimidine based analogues as novel and potent IGF-1R inhibitor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>92 </em>, 246-256. <a href="https://doi.org/10.1016/j.ejmech.2014.12.053" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.12.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.12.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.12.053%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclopentyl-pyrimidine%252Bbased%252Banalogues%252Bas%252Bnovel%252Band%252Bpotent%252BIGF-1R%252Binhibitor%26aulast%3DAware%26aufirst%3DValmik%26date%3D2015%26volume%3D92%26spage%3D246%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayaprakasam  Bolleddula</span>, <span class="hlFld-ContribAuthor ">Kevin  DeMent</span>, <span class="hlFld-ContribAuthor ">James P.  Driscoll</span>, <span class="hlFld-ContribAuthor ">Philip  Worboys</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Brassil</span>, <span class="hlFld-ContribAuthor ">David L.  Bourdet</span>. </span><span class="cited-content_cbyCitation_article-title">Biotransformation and bioactivation reactions of alicyclic amines in drug molecules. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2014,</strong> <em>46 </em>
                                    (3)
                                     , 379-419. <a href="https://doi.org/10.3109/03602532.2014.924962" title="DOI URL">https://doi.org/10.3109/03602532.2014.924962</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/03602532.2014.924962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F03602532.2014.924962%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DBiotransformation%252Band%252Bbioactivation%252Breactions%252Bof%252Balicyclic%252Bamines%252Bin%252Bdrug%252Bmolecules%26aulast%3DBolleddula%26aufirst%3DJayaprakasam%26date%3D2014%26date%3D2014%26volume%3D46%26issue%3D3%26spage%3D379%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue-Cheng  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Lin</span>, <span class="hlFld-ContribAuthor ">Hui-Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Bin  Huang</span>, <span class="hlFld-ContribAuthor ">Da-Qing  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Improved and Efficient Synthesis of Chromeno[4,3-
              d
              ]pyrazolo [3,4-
              b
              ]pyridin-6(3
              H
              )-ones and Their Fluorescence Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2014,</strong> <em>51 </em>
                                    (4)
                                     , 1036-1044. <a href="https://doi.org/10.1002/jhet.2104" title="DOI URL">https://doi.org/10.1002/jhet.2104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2104%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DImproved%252Band%252BEfficient%252BSynthesis%252Bof%252BChromeno%25255B4%25252C3-%252Bd%252B%25255Dpyrazolo%252B%25255B3%25252C4-%252Bb%252B%25255Dpyridin-6%2525283%252BH%252B%252529-ones%252Band%252BTheir%252BFluorescence%252BProperties%26aulast%3DLiu%26aufirst%3DXue-Cheng%26date%3D2014%26date%3D2013%26volume%3D51%26issue%3D4%26spage%3D1036%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taijie  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Li  Sheng</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Youhong  Hu</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro cytotoxic evaluation of novel $$N$$ -(3,4,5-trimethoxyphenyl)pyridin-2( $$1H$$ )-one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2013,</strong> <em>17 </em>
                                    (3)
                                     , 435-444. <a href="https://doi.org/10.1007/s11030-013-9442-1" title="DOI URL">https://doi.org/10.1007/s11030-013-9442-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-013-9442-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-013-9442-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bcytotoxic%252Bevaluation%252Bof%252Bnovel%252B%252524%252524N%252524%252524%252B-%2525283%25252C4%25252C5-trimethoxyphenyl%252529pyridin-2%252528%252B%252524%2525241H%252524%252524%252B%252529-one%252Bderivatives%26aulast%3DChen%26aufirst%3DTaijie%26date%3D2013%26date%3D2013%26volume%3D17%26issue%3D3%26spage%3D435%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taijie  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Youhong  Hu</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>64 </em>, 613-620. <a href="https://doi.org/10.1016/j.ejmech.2013.04.008" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.04.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.04.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B1%25252C6-diaryl%252Bpyridin-2%2525281H%252529-one%252Banalogs%26aulast%3DChen%26aufirst%3DTaijie%26date%3D2013%26volume%3D64%26spage%3D613%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linhao  Li</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Kurt  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Hongbing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An Insulin-Like Growth Factor 1 Receptor Inhibitor Induces CYP3A4 Expression through a Pregnane X Receptor-Independent, Noncanonical Constitutive Androstane Receptor-Related Mechanism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2012,</strong> <em>340 </em>
                                    (3)
                                     , 688-697. <a href="https://doi.org/10.1124/jpet.111.188854" title="DOI URL">https://doi.org/10.1124/jpet.111.188854</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.111.188854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.111.188854%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DAn%252BInsulin-Like%252BGrowth%252BFactor%252B1%252BReceptor%252BInhibitor%252BInduces%252BCYP3A4%252BExpression%252Bthrough%252Ba%252BPregnane%252BX%252BReceptor-Independent%25252C%252BNoncanonical%252BConstitutive%252BAndrostane%252BReceptor-Related%252BMechanism%26aulast%3DLi%26aufirst%3DLinhao%26date%3D2012%26date%3D2011%26volume%3D340%26issue%3D3%26spage%3D688%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meizhong  Jin</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Buck</span>, <span class="hlFld-ContribAuthor ">Mark J  Mulvihill</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule ATP-competitive dual IGF-1R and insulin receptor inhibitors: structural insights, chemical diversity and molecular evolution. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (3)
                                     , 315-328. <a href="https://doi.org/10.4155/fmc.11.180" title="DOI URL">https://doi.org/10.4155/fmc.11.180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.11.180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.11.180%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSmall-molecule%252BATP-competitive%252Bdual%252BIGF-1R%252Band%252Binsulin%252Breceptor%252Binhibitors%25253A%252Bstructural%252Binsights%25252C%252Bchemical%252Bdiversity%252Band%252Bmolecular%252Bevolution%26aulast%3DJin%26aufirst%3DMeizhong%26date%3D2012%26volume%3D4%26issue%3D3%26spage%3D315%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith S.  Learn</span>, <span class="hlFld-ContribAuthor ">Jason C.  Wagner</span>, <span class="hlFld-ContribAuthor ">Mark S.  Albom</span>, <span class="hlFld-ContribAuthor ">Thelma S.  Angeles</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">Arup K.  Ghose</span>, <span class="hlFld-ContribAuthor ">Weihua  Wan</span>, <span class="hlFld-ContribAuthor ">Mangeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Bruce D.  Dorsey</span>, <span class="hlFld-ContribAuthor ">Gregory R.  Ott</span>. </span><span class="cited-content_cbyCitation_article-title">Design of 7-amino-6-chloro-3H-imidazo[4,5-b]pyridine scaffold from 5-chloro-2,4-diaminopyrimidine pharmacophore: identification of potent inhibitors of anaplastic lymphoma kinase. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2012,</strong> <em>3 </em>
                                    (9)
                                     , 1138. <a href="https://doi.org/10.1039/c2md20061a" title="DOI URL">https://doi.org/10.1039/c2md20061a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2md20061a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2md20061a%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%252Bof%252B7-amino-6-chloro-3H-imidazo%25255B4%25252C5-b%25255Dpyridine%252Bscaffold%252Bfrom%252B5-chloro-2%25252C4-diaminopyrimidine%252Bpharmacophore%25253A%252Bidentification%252Bof%252Bpotent%252Binhibitors%252Bof%252Banaplastic%252Blymphoma%252Bkinase%26aulast%3DLearn%26aufirst%3DKeith%2BS.%26date%3D2012%26volume%3D3%26issue%3D9%26spage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Ducray</span>, <span class="hlFld-ContribAuthor ">Iain  Simpson</span>, <span class="hlFld-ContribAuthor ">Frederic H.  Jung</span>, <span class="hlFld-ContribAuthor ">J. Willem M.  Nissink</span>, <span class="hlFld-ContribAuthor ">Peter W.  Kenny</span>, <span class="hlFld-ContribAuthor ">Martina  Fitzek</span>, <span class="hlFld-ContribAuthor ">Graeme E.  Walker</span>, <span class="hlFld-ContribAuthor ">Lara T.  Ward</span>, <span class="hlFld-ContribAuthor ">Kevin  Hudson</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (16)
                                     , 4698-4701. <a href="https://doi.org/10.1016/j.bmcl.2011.06.093" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.06.093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.06.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.06.093%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bimidazo%25255B1%25252C2-a%25255Dpyridines%252Bas%252Binhibitors%252Bof%252Bthe%252Binsulin-like%252Bgrowth%252Bfactor-1%252Breceptor%252Btyrosine%252Bkinase%26aulast%3DDucray%26aufirst%3DRichard%26date%3D2011%26volume%3D21%26issue%3D16%26spage%3D4698%26epage%3D4701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dennis A.  Smith</span>, <span class="hlFld-ContribAuthor ">Li  Di</span>, <span class="hlFld-ContribAuthor ">Edward H.  Kerns</span>. </span><span class="cited-content_cbyCitation_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2010,</strong> <em>9 </em>
                                    (12)
                                     , 929-939. <a href="https://doi.org/10.1038/nrd3287" title="DOI URL">https://doi.org/10.1038/nrd3287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd3287%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DThe%252Beffect%252Bof%252Bplasma%252Bprotein%252Bbinding%252Bon%252Bin%252Bvivo%252Befficacy%25253A%252Bmisconceptions%252Bin%252Bdrug%252Bdiscovery%26aulast%3DSmith%26aufirst%3DDennis%2BA.%26date%3D2010%26date%3D2010%26volume%3D9%26issue%3D12%26spage%3D929%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karen L  Milkiewicz</span>, <span class="hlFld-ContribAuthor ">Gregory R  Ott</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of anaplastic lymphoma kinase: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2010,</strong> <em>20 </em>
                                    (12)
                                     , 1653-1681. <a href="https://doi.org/10.1517/13543776.2010.527332" title="DOI URL">https://doi.org/10.1517/13543776.2010.527332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2010.527332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2010.527332%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInhibitors%252Bof%252Banaplastic%252Blymphoma%252Bkinase%25253A%252Ba%252Bpatent%252Breview%26aulast%3DMilkiewicz%26aufirst%3DKaren%2BL%26date%3D2010%26date%3D2010%26volume%3D20%26issue%3D12%26spage%3D1653%26epage%3D1681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Remigijus  Didziapetris</span>, <span class="hlFld-ContribAuthor ">Justas  Dapkunas</span>, <span class="hlFld-ContribAuthor ">Andrius  Sazonovas</span>, <span class="hlFld-ContribAuthor ">Pranas  Japertas</span>. </span><span class="cited-content_cbyCitation_article-title">Trainable structure–activity relationship model for virtual screening of CYP3A4 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2010,</strong> <em>24 </em>
                                    (11)
                                     , 891-906. <a href="https://doi.org/10.1007/s10822-010-9381-1" title="DOI URL">https://doi.org/10.1007/s10822-010-9381-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-010-9381-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-010-9381-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DTrainable%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bmodel%252Bfor%252Bvirtual%252Bscreening%252Bof%252BCYP3A4%252Binhibition%26aulast%3DDidziapetris%26aufirst%3DRemigijus%26date%3D2010%26date%3D2010%26volume%3D24%26issue%3D11%26spage%3D891%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gideon P.  Ewing</span>, <span class="hlFld-ContribAuthor ">Laura W.  Goff</span>. </span><span class="cited-content_cbyCitation_article-title">The Insulin-like Growth Factor Signaling Pathway as a Target for Treatment of Colorectal Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Clinical Colorectal Cancer</span><span> <strong>2010,</strong> <em>9 </em>
                                    (4)
                                     , 219-223. <a href="https://doi.org/10.3816/CCC.2010.n.032" title="DOI URL">https://doi.org/10.3816/CCC.2010.n.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3816/CCC.2010.n.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3816%2FCCC.2010.n.032%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Colorectal%2520Cancer%26atitle%3DThe%252BInsulin-like%252BGrowth%252BFactor%252BSignaling%252BPathway%252Bas%252Ba%252BTarget%252Bfor%252BTreatment%252Bof%252BColorectal%252BCarcinoma%26aulast%3DEwing%26aufirst%3DGideon%2BP.%26date%3D2010%26volume%3D9%26issue%3D4%26spage%3D219%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Upender  Velaparthi</span>, <span class="hlFld-ContribAuthor ">Mark G.  Saulnier</span>, <span class="hlFld-ContribAuthor ">Mark D.  Wittman</span>, <span class="hlFld-ContribAuthor ">Peiying  Liu</span>, <span class="hlFld-ContribAuthor ">David B.  Frennesson</span>, <span class="hlFld-ContribAuthor ">Kurt  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Joan M.  Carboni</span>, <span class="hlFld-ContribAuthor ">Marco  Gottardis</span>, <span class="hlFld-ContribAuthor ">Aixin  Li</span>, <span class="hlFld-ContribAuthor ">Ann  Greer</span>, <span class="hlFld-ContribAuthor ">Wendy  Clarke</span>, <span class="hlFld-ContribAuthor ">Zheng  Yang</span>, <span class="hlFld-ContribAuthor ">Krista  Menard</span>, <span class="hlFld-ContribAuthor ">Francis Y.  Lee</span>, <span class="hlFld-ContribAuthor ">George  Trainor</span>, <span class="hlFld-ContribAuthor ">Dolatrai  Vyas</span>. </span><span class="cited-content_cbyCitation_article-title">Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (10)
                                     , 3182-3185. <a href="https://doi.org/10.1016/j.bmcl.2010.03.057" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.03.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.03.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.03.057%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInsulin-like%252Bgrowth%252Bfactor-1%252Breceptor%252B%252528IGF-1R%252529%252Bkinase%252Binhibitors%25253A%252BSAR%252Bof%252Ba%252Bseries%252Bof%252B3-%25255B6-%2525284-substituted-piperazin-1-yl%252529-4-methyl-1H-benzimidazol-2-yl%25255D-1H-pyridine-2-one%26aulast%3DVelaparthi%26aufirst%3DUpender%26date%3D2010%26volume%3D20%26issue%3D10%26spage%3D3182%26epage%3D3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kurt  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Mark D.  Wittman</span>, <span class="hlFld-ContribAuthor ">Mark G.  Saulnier</span>, <span class="hlFld-ContribAuthor ">Upender  Velaparthi</span>, <span class="hlFld-ContribAuthor ">Xiaopeng  Sang</span>, <span class="hlFld-ContribAuthor ">David B.  Frennesson</span>, <span class="hlFld-ContribAuthor ">Charles  Struzynski</span>, <span class="hlFld-ContribAuthor ">Steven P.  Seitz</span>, <span class="hlFld-ContribAuthor ">Liqi  He</span>, <span class="hlFld-ContribAuthor ">Joan M.  Carboni</span>, <span class="hlFld-ContribAuthor ">Aixin  Li</span>, <span class="hlFld-ContribAuthor ">Ann F.  Greer</span>, <span class="hlFld-ContribAuthor ">Marco  Gottardis</span>, <span class="hlFld-ContribAuthor ">Ricardo M.  Attar</span>, <span class="hlFld-ContribAuthor ">Zheng  Yang</span>, <span class="hlFld-ContribAuthor ">Praveen  Balimane</span>, <span class="hlFld-ContribAuthor ">Lorell N.  Discenza</span>, <span class="hlFld-ContribAuthor ">Francis Y.  Lee</span>, <span class="hlFld-ContribAuthor ">Michael  Sinz</span>, <span class="hlFld-ContribAuthor ">Sean  Kim</span>, <span class="hlFld-ContribAuthor ">Dolatrai  Vyas</span>. </span><span class="cited-content_cbyCitation_article-title">SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (5)
                                     , 1744-1748. <a href="https://doi.org/10.1016/j.bmcl.2010.01.087" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.087%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSAR%252Bof%252BPXR%252Btransactivation%252Bin%252Bbenzimidazole-based%252BIGF-1R%252Bkinase%252Binhibitors%26aulast%3DZimmermann%26aufirst%3DKurt%26date%3D2010%26volume%3D20%26issue%3D5%26spage%3D1744%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark J  Mulvihill</span>, <span class="hlFld-ContribAuthor ">Andrew  Cooke</span>, <span class="hlFld-ContribAuthor ">Maryland  Rosenfeld-Franklin</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Buck</span>, <span class="hlFld-ContribAuthor ">Ken  Foreman</span>, <span class="hlFld-ContribAuthor ">Darla  Landfair</span>, <span class="hlFld-ContribAuthor ">Matthew  O’Connor</span>, <span class="hlFld-ContribAuthor ">Caroline  Pirritt</span>, <span class="hlFld-ContribAuthor ">Yingchaun  Sun</span>, <span class="hlFld-ContribAuthor ">Yan  Yao</span>, <span class="hlFld-ContribAuthor ">Lee D  Arnold</span>, <span class="hlFld-ContribAuthor ">Neil W  Gibson</span>, <span class="hlFld-ContribAuthor ">Qun-Sheng  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2009,</strong> <em>1 </em>
                                    (6)
                                     , 1153-1171. <a href="https://doi.org/10.4155/fmc.09.89" title="DOI URL">https://doi.org/10.4155/fmc.09.89</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.09.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.09.89%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BOSI-906%25253A%252Ba%252Bselective%252Band%252Borally%252Befficacious%252Bdual%252Binhibitor%252Bof%252Bthe%252BIGF-1%252Breceptor%252Band%252Binsulin%252Breceptor%26aulast%3DMulvihill%26aufirst%3DMark%2BJ%26date%3D2009%26volume%3D1%26issue%3D6%26spage%3D1153%26epage%3D1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tara R.  Rheault</span>, <span class="hlFld-ContribAuthor ">Kelly H.  Donaldson</span>, <span class="hlFld-ContribAuthor ">Mui  Cheung</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient synthesis of heteroaryl-linked benzimidazoles via microwave-assisted boronate ester formation. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2009,</strong> <em>50 </em>
                                    (13)
                                     , 1399-1402. <a href="https://doi.org/10.1016/j.tetlet.2009.01.087" title="DOI URL">https://doi.org/10.1016/j.tetlet.2009.01.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2009.01.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2009.01.087%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DConvenient%252Bsynthesis%252Bof%252Bheteroaryl-linked%252Bbenzimidazoles%252Bvia%252Bmicrowave-assisted%252Bboronate%252Bester%252Bformation%26aulast%3DRheault%26aufirst%3DTara%2BR.%26date%3D2009%26volume%3D50%26issue%3D13%26spage%3D1399%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark D.  Wittman</span>, <span class="hlFld-ContribAuthor ">Upender  Velaparthi</span>, <span class="hlFld-ContribAuthor ">Dolatrai M.  Vyas</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 14 Recent Progress in the Development of Small Molecule Inhibitors of Insulin-Like Growth Factor-1 Receptor Kinase. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2009,</strong>,, 281-299. <a href="https://doi.org/10.1016/S0065-7743(09)04414-5" title="DOI URL">https://doi.org/10.1016/S0065-7743(09)04414-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0065-7743(09)04414-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0065-7743%2809%2904414-5%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B14%252BRecent%252BProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BSmall%252BMolecule%252BInhibitors%252Bof%252BInsulin-Like%252BGrowth%252BFactor-1%252BReceptor%252BKinase%26aulast%3DWittman%26aufirst%3DMark%2BD.%26date%3D2009%26spage%3D281%26epage%3D299%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B44%26date%3D2009%26volume%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/medium/jm-2008-00832q_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/large/jm-2008-00832q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800832q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/medium/jm-2008-00832q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/large/jm-2008-00832q_0004.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/large/jm-2008-00832q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800832q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) bis(pinacolato)diborane, PdCl<sub>2</sub>(dppf)<sub>2</sub>, KOAc, DMSO; (b) <b>13</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, LiCl, Na<sub>2</sub>CO<sub>3</sub>, DME; (c) 10% Pd−C/MeOH H<sub>2</sub>, 4-iodo-2-methoxynicotinaldehyde (<b>15)</b>/MeOH; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 3-fluoropropylbromide; (e) 4NHCl/dioxane; (f) 2-(4-chloro-1<i>H</i>-pyrazol-1-yl)ethanamine, Et<sub>3</sub>N/CH<sub>3</sub>CN/85 °C.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/medium/jm-2008-00832q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/large/jm-2008-00832q_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Efficacy of <b>1</b> and <b>10</b> in Colo205 (human colon carcinoma, BID × 21).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-19/jm800832q/production/images/large/jm-2008-00832q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800832q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i10">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26478" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26478" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hubbard, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. T.</span><span> </span><span class="NLM_article-title">Receptor tyrosine kinases: mechanisms of activation and signaling</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1016%2Fj.ceb.2007.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=17306972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=117-123&author=S.+R.+Hubbardauthor=W.+T.+Miller&title=Receptor+tyrosine+kinases%3A+mechanisms+of+activation+and+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor tyrosine kinases: mechanisms of activation and signaling</span></div><div class="casAuthors">Hubbard, Stevan R.; Miller, W. Todd</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-123</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases (RTKs) are essential components of signal transduction pathways that mediate cell-to-cell communication.  These single-pass transmembrane receptors, which bind polypeptide ligands - mainly growth factors - play key roles in processes such as cellular growth, differentiation, metab. and motility.  Recent progress has been achieved towards an understanding of the precise (and varied) mechanisms by which RTKs are activated by ligand binding and by which signals are propagated from the activated receptors to downstream targets in the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg3ej9ekC3hLVg90H21EOLACvtfcHk0lg8Ia8ECRJfpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu78%253D&md5=254110135c0f1a5642441c551d379bef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2007.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2007.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26aulast%3DMiller%26aufirst%3DW.%2BT.%26atitle%3DReceptor%2520tyrosine%2520kinases%253A%2520mechanisms%2520of%2520activation%2520and%2520signaling%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2007%26volume%3D19%26spage%3D117%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Liao, J, J.</span><span> </span><span class="NLM_article-title">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J%2C+J.+Liao&title=Molecular+Recognition+of+Protein+Kinase+Binding+Pockets+for+Design+of+Potent+and+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0lg8Ia8ECRJfpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ%252C%2BJ.%26atitle%3DMolecular%2520Recognition%2520of%2520Protein%2520Kinase%2520Binding%2520Pockets%2520for%2520Design%2520of%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">LeRoith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. T.</span><span> </span><span class="NLM_article-title">The insulin-like growth factor system and cancer</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1016%2FS0304-3835%2803%2900159-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=12767520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFWmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2003&pages=127-137&author=D.+LeRoithauthor=C.+T.+Roberts&title=The+insulin-like+growth+factor+system+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The insulin-like growth factor system and cancer</span></div><div class="casAuthors">LeRoith, Derek; Roberts, Charles T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-137</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The insulin-like growth factor (IGF) family of ligands, binding proteins and receptors is an important growth factor system involved in both the development of the organism and the maintenance of normal function of many cells of the body.  The system also has powerful anti-apoptotic effects.  More recently, evidence has accrued to demonstrate that the IGFs play an important role in cancer.  Individuals with serum IGF-II levels in the upper quartile of the normal range (and IGF binding protein-3 levels in the lower quartiles) have a relative risk for developing breast, prostate, colon and lung cancer.  IGF-II is commonly expressed by tumor cells and may act as an autocrine growth factor; occasionally even reaching target tissues and causing tumor-induced hypoglycemia.  The IGF-I receptor is commonly (though not always) overexpressed in many cancers, and many recent studies have identified new signaling pathways emanating from the IGF-I receptor that affect cancer cell proliferation, adhesion, migration and cell death; functions that are crit. for cancer cell survival and metastases.  In this review, many aspects of the IGF system and its relationship to cancer will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDripN7XEWorVg90H21EOLACvtfcHk0lg8Ia8ECRJfpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFWmsrk%253D&md5=0515c75e9673e1e3ca6ce41f512a2e2f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0304-3835%2803%2900159-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3835%252803%252900159-9%26sid%3Dliteratum%253Aachs%26aulast%3DLeRoith%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DC.%2BT.%26atitle%3DThe%2520insulin-like%2520growth%2520factor%2520system%2520and%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2003%26volume%3D195%26spage%3D127%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Baserga, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peruzzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, K.</span><span> </span><span class="NLM_article-title">The IGF-1 receptor in cancer biology</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1002%2Fijc.11487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=14601044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFOgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2003&pages=873-877&author=R.+Basergaauthor=F.+Peruzziauthor=K.+Reiss&title=The+IGF-1+receptor+in+cancer+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The IGF-1 receptor in cancer biology</span></div><div class="casAuthors">Baserga, Renato; Peruzzi, Francesca; Reiss, Krysztof</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">873-877</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The type I insulin-like growth factor receptor (IGF-IR) plays an important role in the establishment and maintenance of the transformed phenotype.  It also has a strong antiapoptotic activity and has a significant influence on the control of cell and body size.  Downregulation of the IGF-IR leads to massive apoptosis of cancer cells.  These characteristics make it an attractive target for anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVej94ZLdT8LVg90H21EOLACvtfcHk0lgTUlDBgzNoFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFOgt7g%253D&md5=53aed4634fd9a52c0b3836a9c40991e0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fijc.11487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.11487%26sid%3Dliteratum%253Aachs%26aulast%3DBaserga%26aufirst%3DR.%26aulast%3DPeruzzi%26aufirst%3DF.%26aulast%3DReiss%26aufirst%3DK.%26atitle%3DThe%2520IGF-1%2520receptor%2520in%2520cancer%2520biology%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2003%26volume%3D107%26spage%3D873%26epage%3D877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohan, T.</span><span> </span><span class="NLM_article-title">J. Role of insulin-like growth factor family in cancer development and progression</span> <span class="citation_source-journal">Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">1472</span><span class="NLM_x">–</span> <span class="NLM_lpage">1489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1093%2Fjnci%2F92.18.1472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFKqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=1472-1489&issue=18&author=H.+Yuauthor=T.+Rohan&title=J.+Role+of+insulin-like+growth+factor+family+in+cancer+development+and+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the insulin-like growth factor family in cancer development and progression</span></div><div class="casAuthors">Yu, Herbert; Rohan, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1472-1489</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with ~ 316 refs.  The insulin-like growth factors (IGFs) are mitogens that play a pivotal role in regulating cell proliferation, differentiation, and apoptosis.  The effects of IGFs are mediated through the IGF-I receptor, which is also involved in cell transformation induced by tumor virus proteins and oncogene products.  Six IGF-binding proteins (IGFBPs) can inhibit or enhance the actions of IGFs.  These opposing effects are detd. by the structures of the binding proteins.  The effects of IGFBPs on IGFs are regulated in part by IGFBP proteases.  Lab. studies have shown that IGFs exert strong mitogenic and antiapoptotic actions on various cancer cells.  IGFs also act synergistically with other mitogenic growth factors and steroids and antagonize the effect of antiproliferative mols. on cancer growth.  The role of IGFs in cancer is supported by epidemiol. studies, which have found that high levels of circulating IGF-I and low levels of IGFBP-3 are assocd. with increased risk of several common cancers, including those of the prostate, breast, colorectum, and lung.  Evidence further suggests that certain lifestyles, such as one involving a high-energy diet, may increase IGF-I levels, a finding that is supported by animal expts. indicating that IGFs may abolish the inhibitory effect of energy restriction on cancer growth.  Further investigation of the role of IGFs in linking high energy intake, increased cell proliferation, suppression of apoptosis, and increased cancer risk may provide new insights into the etiol. of cancer and lead to new strategies for cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcx6kqz1pqXbVg90H21EOLACvtfcHk0lgTUlDBgzNoFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFKqsrw%253D&md5=f44af04e26bff771da45aafc7ccbeb98</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.18.1472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.18.1472%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DRohan%26aufirst%3DT.%26atitle%3DJ.%2520Role%2520of%2520insulin-like%2520growth%2520factor%2520family%2520in%2520cancer%2520development%2520and%2520progression%26jtitle%3DNatl.%2520Cancer%2520Inst.%26date%3D2000%26volume%3D92%26issue%3D18%26spage%3D1472%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">White, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogarty, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werther, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wraight, C. J.</span><span> </span><span class="NLM_article-title">Antisense inhibition of IGF-1 receptor expression in HaCaT keratinocytes: a model for antisense strategies in keratinocytes. Antisense</span> <span class="citation_source-journal">Nucleic Acid Drug Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=10905556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks12ju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=195-203&author=P.+J.+Whiteauthor=R.+D.+Fogartyauthor=G.+A.+Wertherauthor=C.+J.+Wraight&title=Antisense+inhibition+of+IGF-1+receptor+expression+in+HaCaT+keratinocytes%3A+a+model+for+antisense+strategies+in+keratinocytes.+Antisense"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antisense inhibition of IGF receptor expression in HaCaT keratinocytes: a model for antisense strategies in keratinocytes</span></div><div class="casAuthors">White, P. J.; Fogarty, R. D.; Werther, G. A.; Wraight, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Antisense & Nucleic Acid Drug Development</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">195-203</span>CODEN:
                <span class="NLM_cas:coden">ANADF5</span>;
        ISSN:<span class="NLM_cas:issn">1087-2906</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Antisense strategies targeting skin conditions are attractive in concept, with a no. of possible pathol. conditions, such a psoriasis, apparently suitable for such an approach.  Because in vitro screening of candidate sequences is usually desirable, we have attempted to use a range of new generation cationic lipids to produce significant antisense oligodeoxynucleotide (ODN) uptake in an immortalized keratinocyte cell line (HaCaT).  A large no. of com. available lipids were screened for the ability to induce nuclear ODN localization: Tfx-50, Tfx-20, Tfx-10, Superfect, Cytofectin GSV, Perfect lipids 1-8, Lipofectin, and Lipofectamine.  All lipids were used at a range of concns. (1-20 μg/mL) and with a range of ODN concns. (1-1000) nM.  Of all lipids used, only Cytofectin GSV and Superfect produced significant (>30% of cells) levels of nuclear pos. cells, with Superfect also producing significant toxicity at the effective concn. used.  Only two treatments produced a significant redn. in target mRNA: insulin-like growth factor-1 receptor (IGF-1R)-ODN 64 complexed with Cytofectin GSV (27.1% ± 3.5% of IGF-1R mRNA in untreated cells, p < 0.01) and ODN 64 complexed with 10 μg/mL Lipofectin (62.2% ± 3.4% of IGF-1R mRNA in untreated cells, p < 0.05).  Only one treatment, ODN 64 complexed with Cytofectin GSV, produced a redn. in cell growth and survival as assessed by amido black assay.  These results demonstrate that in HaCaT keratinocytes, Cytofectin GSV alone of all com. available cationic lipids was effective in delivering antisense ODN into cell nuclei such that a profound antisense effect could be demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq43trqbVcI_LVg90H21EOLACvtfcHk0lgTUlDBgzNoFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks12ju7w%253D&md5=f267a6f32439b11d91c5b224d27fddc8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DP.%2BJ.%26aulast%3DFogarty%26aufirst%3DR.%2BD.%26aulast%3DWerther%26aufirst%3DG.%2BA.%26aulast%3DWraight%26aufirst%3DC.%2BJ.%26atitle%3DAntisense%2520inhibition%2520of%2520IGF-1%2520receptor%2520expression%2520in%2520HaCaT%2520keratinocytes%253A%2520a%2520model%2520for%2520antisense%2520strategies%2520in%2520keratinocytes.%2520Antisense%26jtitle%3DNucleic%2520Acid%2520Drug%2520Dev.%26date%3D2000%26volume%3D10%26spage%3D195%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">De Leon, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfield, R. G.</span><span> </span><span class="NLM_article-title">Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells</span> <span class="citation_source-journal">Growth Factors</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=327-336&author=D.+D.+De+Leonauthor=D.+M.+Wilsonauthor=M.+Powersauthor=R.+G.+Rosenfield&title=Effects+of+insulin-like+growth+factors+%28IGFs%29+and+IGF+receptor+antibodies+on+the+proliferation+of+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLeon%26aufirst%3DD.%2BD.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DPowers%26aufirst%3DM.%26aulast%3DRosenfield%26aufirst%3DR.%2BG.%26atitle%3DEffects%2520of%2520insulin-like%2520growth%2520factors%2520%2528IGFs%2529%2520and%2520IGF%2520receptor%2520antibodies%2520on%2520the%2520proliferation%2520of%2520human%2520breast%2520cancer%2520cells%26jtitle%3DGrowth%2520Factors%26date%3D1992%26volume%3D6%26spage%3D327%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Reiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Ambosio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baserga, R.</span><span> </span><span class="NLM_article-title">Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=9829727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADyaK1cXns1Ogtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=2647-2655&author=K.+Reissauthor=C.+D%E2%80%99Ambosioauthor=X.+Tuauthor=C.+Tuauthor=R.+Baserga&title=Inhibition+of+tumor+growth+by+a+dominant+negative+mutant+of+the+insulin-like+growth+factor+I+receptor+with+a+bystander+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect</span></div><div class="casAuthors">Reiss, Krzysztof; D'Ambrosio, Consuelo; Tu, Xiao; Tu, Chi; Baserga, Renato</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2647-2655</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The insulin-like growth factor I receptor is known to play a major role in transformation and apoptosis.  The dominant neg. mutant of the insulin-like growth factor I receptor, designated 486/STOP, causes massive apoptosis of tumor cells and inhibition of tumor growth and metastases.  We now show that: (a) the stable expression of 486/STOP inhibits transformation (colony formation in soft agar) and/or tumor growth in nude mice of five different types of human tumor cell lines; and (b) more importantly, it has a bystander effect, inhibiting the growth of wild-type tumor cells when cells expressing 486/STOP are coinjected with wild-type tumor cells.  These findings suggest that it is not necessary to infect all tumor cells with 486/STOP to inhibit tumor growth, and they also open the possibility of using the product of 486/STOP directly against tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC5Qzw9X_zP7Vg90H21EOLACvtfcHk0lhTufB5XMr1_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1Ogtb0%253D&md5=b03f84c833c15f57605bbaaf7d7b6668</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReiss%26aufirst%3DK.%26aulast%3DD%25E2%2580%2599Ambosio%26aufirst%3DC.%26aulast%3DTu%26aufirst%3DX.%26aulast%3DTu%26aufirst%3DC.%26aulast%3DBaserga%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520tumor%2520growth%2520by%2520a%2520dominant%2520negative%2520mutant%2520of%2520the%2520insulin-like%2520growth%2520factor%2520I%2520receptor%2520with%2520a%2520bystander%2520effect%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1998%26volume%3D4%26spage%3D2647%26epage%3D2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stampfer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannucci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gann, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennekesn, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollak, M.</span><span> </span><span class="NLM_article-title">Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study</span> <span class="citation_source-journal">Science (Washington, D.C.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1126%2Fscience.279.5350.563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=9438850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADyaK1cXotVOqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=563-566&author=J.+M.+Chanauthor=M.+J.+Stampferauthor=E.+Giovannucciauthor=P.+H.+Gannauthor=J.+Maauthor=P.+Wilkinsonauthor=C.+H.+Hennekesnauthor=M.+Pollak&title=Plasma+insulin-like+growth+factor-I+and+prostate+cancer+risk%3A+a+prospective+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study</span></div><div class="casAuthors">Chan, June M.; Stempfer, Meir J.; Giovannucci, Edward; Gann, Peter H.; Ma, Jing; Wilkinson, Peter; Hennekens, Charles H.; Pollak, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">5350</span>),
    <span class="NLM_cas:pages">563-566</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Insulin-like growth factor-I (IGF-I) is a mitogen for prostate epithelial cells.  To investigate assocns. between plasma IGF levels and prostate cancer risk, a nested case-control study within the Physicians' health Study was conducted on prospectively collected plasma from 152 cases and 152 controls.  A strong pos. assocn. was obsd. between IGF-I levels and prostate cancer risk.  Men in the highest quartile of IGF-I levels had a relative risk of 4.3 (95 % confidence interval 1.8 to 10.6) compared with men in the lowest quartile.  This assocn. was independent of baseline prostate-specific antigen levels.  Identification of plasma IGF-I as a predictor of prostate cancer risk may have implications for risk redn. and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN8T4rIgzxMLVg90H21EOLACvtfcHk0lhTufB5XMr1_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVOqsg%253D%253D&md5=43c076479c5fb946f61a42758043bd92</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.279.5350.563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.279.5350.563%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DJ.%2BM.%26aulast%3DStampfer%26aufirst%3DM.%2BJ.%26aulast%3DGiovannucci%26aufirst%3DE.%26aulast%3DGann%26aufirst%3DP.%2BH.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWilkinson%26aufirst%3DP.%26aulast%3DHennekesn%26aufirst%3DC.%2BH.%26aulast%3DPollak%26aufirst%3DM.%26atitle%3DPlasma%2520insulin-like%2520growth%2520factor-I%2520and%2520prostate%2520cancer%2520risk%253A%2520a%2520prospective%2520study%26jtitle%3DScience%2520%2528Washington%252C%2520D.C.%2529%26date%3D1998%26volume%3D279%26spage%3D563%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Wittman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balimane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eummer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frennesson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurlburt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnananthan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoeckler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span> </span><span class="NLM_article-title">Discovery of a (1<i>H</i>-benzimidazol-2-yl)-1<i>H</i>-pyridine-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5639</span><span class="NLM_x">–</span> <span class="NLM_lpage">5643</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050392q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5639-5643&author=M.+Wittmanauthor=J.+Carboniauthor=F.+Attarauthor=B.+Balasubramanianauthor=P.+Balimaneauthor=P.+Brassilauthor=F.+Beaulieuauthor=C.+Changauthor=W.+Clarkeauthor=J.+Dellauthor=J.+Eummerauthor=D.+Frennessonauthor=M.+Gottardisauthor=A.+Greerauthor=S.+Hanselauthor=W.+Hurlburtauthor=B.+Jacobsonauthor=S.+Krishnananthanauthor=F.+Y.+Leeauthor=A.+Liauthor=T.-A.+Linauthor=P.+Liuauthor=C.+Ouelletauthor=X.+Sangauthor=M.+G.+Saulnierauthor=K.+Stoffanauthor=Y.+Sunauthor=U.+Velaparthiauthor=D.+Vyasauthor=H.+Wongauthor=Z.+Yangauthor=K.+Zimmermannauthor=M.+Zoecklerauthor=D.+Vyas&title=Discovery+of+a+%281H-benzimidazol-2-yl%29-1H-pyridine-2-one+%28BMS-536924%29+inhibitor+of+insulin-like+growth+factor+I+receptor+kinase+with+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm050392q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050392q%26sid%3Dliteratum%253Aachs%26aulast%3DWittman%26aufirst%3DM.%26aulast%3DCarboni%26aufirst%3DJ.%26aulast%3DAttar%26aufirst%3DF.%26aulast%3DBalasubramanian%26aufirst%3DB.%26aulast%3DBalimane%26aufirst%3DP.%26aulast%3DBrassil%26aufirst%3DP.%26aulast%3DBeaulieu%26aufirst%3DF.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DClarke%26aufirst%3DW.%26aulast%3DDell%26aufirst%3DJ.%26aulast%3DEummer%26aufirst%3DJ.%26aulast%3DFrennesson%26aufirst%3DD.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DGreer%26aufirst%3DA.%26aulast%3DHansel%26aufirst%3DS.%26aulast%3DHurlburt%26aufirst%3DW.%26aulast%3DJacobson%26aufirst%3DB.%26aulast%3DKrishnananthan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DT.-A.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DOuellet%26aufirst%3DC.%26aulast%3DSang%26aufirst%3DX.%26aulast%3DSaulnier%26aufirst%3DM.%2BG.%26aulast%3DStoffan%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DVyas%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DZoeckler%26aufirst%3DM.%26aulast%3DVyas%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520%25281H-benzimidazol-2-yl%2529-1H-pyridine-2-one%2520%2528BMS-536924%2529%2520inhibitor%2520of%2520insulin-like%2520growth%2520factor%2520I%2520receptor%2520kinase%2520with%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5639%26epage%3D5643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references cited therein.</p></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ji, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld-Franklin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirritt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyzaguirre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachter, J. A.</span><span> </span><span class="NLM_article-title">A novel, potent, and selective insulin-like growth factor-1 receptor kinase inhibitor blocks insulin-like growth factor-1 receptor signaling in vitro and inhibits insulin-like growth factor-1 receptor dependent tumor growth in vivo</span> <span class="citation_source-journal">Mol. Cancer. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2158</span><span class="NLM_x">–</span> <span class="NLM_lpage">2167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1158%2F1535-7163.MCT-07-0070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=17671083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVGltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2158-2167&issue=8&author=Q.-S.+Jiauthor=M.+Mulvihillauthor=M.+Rosenfeld-Franklinauthor=A.+Cookeauthor=L.+Fengauthor=G.+Makauthor=M.+O%E2%80%99Connorauthor=Y.+Yaoauthor=C.+Pirrittauthor=E.+Buckauthor=A.+Eyzaguirreauthor=L.+D.+Arnoldauthor=N.+W.+Gibsonauthor=J.+A.+Pachter&title=A+novel%2C+potent%2C+and+selective+insulin-like+growth+factor-1+receptor+kinase+inhibitor+blocks+insulin-like+growth+factor-1+receptor+signaling+in+vitro+and+inhibits+insulin-like+growth+factor-1+receptor+dependent+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor-dependent tumor growth in vivo</span></div><div class="casAuthors">Ji, Qun-sheng; Mulvihill, Mark J.; Rosenfeld-Franklin, Maryland; Cooke, Andrew; Feng, Lixin; Mak, Gilda; O'Connor, Matthew; Yao, Yan; Pirritt, Caroline; Buck, Elizabeth; Eyzaguirre, Alexandra; Arnold, Lee D.; Gibson, Neil W.; Pachter, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2158-2167</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Insulin-like growth factor-I receptor (IGF-IR) and its ligands, IGF-I and IGF-II, are up-regulated in a variety of human cancers.  In tumors, such as colorectal, non-small cell lung, ovarian, and pediatric cancers, which may drive their own growth and survival through autocrine IGF-II expression, the role of IGF-IR is esp. crit.  Here, we present a novel small-mol. IGF-IR kinase inhibitor, cis-3-[3-(4-methyl-piperazin-l-yl)-cyclobutyl]-1-(2-phenyl-quinolin-7-yl)-imidazo[1,5-a]pyrazin-8-ylamine (PQIP), which displayed a cellular IC50 of 19 nmol/L for inhibition of ligand-dependent autophosphorylation of human IGF-IR with 14-fold cellular selectivity relative to the human insulin receptor.  PQIP showed minimal activity against a panel of 32 other protein kinases.  It also abolished the ligand-induced activation of downstream phosphorylated AKT and phosphorylated extracellular signal-regulated kinase 1/2 in both IGF-IR transfectant cells and a GEO human colorectal cancer cell line.  Anal. of GEO cells revealed a significant level of both phosphorylated IGF-IR and IGF-II expression.  Furthermore, inactivation of IGF-II in conditioned GEO culture medium by a neutralizing antibody diminished IGF-IR activation, indicating the presence of a functional IGF-II/IGF-IR autocrine loop in GEO cells.  Once daily oral dosing of PQIP induced robust antitumor efficacy in GEO xenografts.  The antitumor efficacy correlated with the degree and duration of inhibition of tumor IGF-IR phosphorylation in vivo by this compd.  Moreover, when mice were treated for 3 days with a dose of PQIP that maximally inhibited tumor growth, only minor changes in blood glucose were obsd.  Thus, PQIP represents a potent and selective IGF-IR kinase inhibitor that is esp. efficacious in an IGF-II-driven human tumor model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUljsbsd3CzbVg90H21EOLACvtfcHk0lj9K4qqcHWW6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVGltLg%253D&md5=d0d7c5cb6b4ec09893b3ff178f4613d7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0070%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DQ.-S.%26aulast%3DMulvihill%26aufirst%3DM.%26aulast%3DRosenfeld-Franklin%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DPirritt%26aufirst%3DC.%26aulast%3DBuck%26aufirst%3DE.%26aulast%3DEyzaguirre%26aufirst%3DA.%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26aulast%3DPachter%26aufirst%3DJ.%2BA.%26atitle%3DA%2520novel%252C%2520potent%252C%2520and%2520selective%2520insulin-like%2520growth%2520factor-1%2520receptor%2520kinase%2520inhibitor%2520blocks%2520insulin-like%2520growth%2520factor-1%2520receptor%2520signaling%2520in%2520vitro%2520and%2520inhibits%2520insulin-like%2520growth%2520factor-1%2520receptor%2520dependent%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DMol.%2520Cancer.%2520Ther.%26date%3D2007%26volume%3D6%26issue%3D8%26spage%3D2158%26epage%3D2167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Haluska, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loegering, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frennesson, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalli, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conover, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlichman, C.</span><span> </span><span class="NLM_article-title">In vitro and in vivo antitumor effects of dual insulin-like growth factor-1/insulin receptor inhibitor, BMS-554417</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=362-371&author=P.+Haluskaauthor=J.+M.+Carboniauthor=D.+A.+Loegeringauthor=F.+Y.+Leeauthor=M.+Wittmanauthor=M.+G.+Saulnierauthor=D.+B.+Frennessonauthor=D.+A.+Kalliauthor=C.+A.+Conoverauthor=R.+M.+Attarauthor=S.+H.+Kaufmannauthor=M.+Gottardisauthor=C.+Erlichman&title=In+vitro+and+in+vivo+antitumor+effects+of+dual+insulin-like+growth+factor-1%2Finsulin+receptor+inhibitor%2C+BMS-554417"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaluska%26aufirst%3DP.%26aulast%3DCarboni%26aufirst%3DJ.%2BM.%26aulast%3DLoegering%26aufirst%3DD.%2BA.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DWittman%26aufirst%3DM.%26aulast%3DSaulnier%26aufirst%3DM.%2BG.%26aulast%3DFrennesson%26aufirst%3DD.%2BB.%26aulast%3DKalli%26aufirst%3DD.%2BA.%26aulast%3DConover%26aufirst%3DC.%2BA.%26aulast%3DAttar%26aufirst%3DR.%2BM.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DErlichman%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520effects%2520of%2520dual%2520insulin-like%2520growth%2520factor-1%252Finsulin%2520receptor%2520inhibitor%252C%2520BMS-554417%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D362%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoeckler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span> </span><span class="NLM_article-title">Imidazole moiety replacements in the 3-(1<i>H</i>-benzo[<i>d</i>]imidazole-2-yl)pyridine-2(1<i>H</i>)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3072</span><span class="NLM_x">–</span> <span class="NLM_lpage">3076</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3072-3076&author=U.+Velaparthiauthor=P.+Liuauthor=B.+Balasubramanianauthor=J.+Carboniauthor=R.+Attarauthor=M.+Gottardisauthor=A.+Liauthor=A.+Greerauthor=M.+Zoecklerauthor=M.+D.+Wittmanauthor=D.+Vyas&title=Imidazole+moiety+replacements+in+the+3-%281H-benzo%5Bd%5Dimidazole-2-yl%29pyridine-2%281H%29-one+inhibitors+of+insulin-like+growth+factor+receptor-1+%28IGF-1R%29+to+improve+cytochrome+P450+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DB.%26aulast%3DCarboni%26aufirst%3DJ.%26aulast%3DAttar%26aufirst%3DR.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DGreer%26aufirst%3DA.%26aulast%3DZoeckler%26aufirst%3DM.%26aulast%3DWittman%26aufirst%3DM.%2BD.%26aulast%3DVyas%26aufirst%3DD.%26atitle%3DImidazole%2520moiety%2520replacements%2520in%2520the%25203-%25281H-benzo%255Bd%255Dimidazole-2-yl%2529pyridine-2%25281H%2529-one%2520inhibitors%2520of%2520insulin-like%2520growth%2520factor%2520receptor-1%2520%2528IGF-1R%2529%2520to%2520improve%2520cytochrome%2520P450%2520profile%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3072%26epage%3D3076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span> </span><span class="NLM_article-title">Discovery and initial SAR of 3-(1<i>H</i>-benzo[<i>d</i>]imidazole-2-yl)pyridine-2(1<i>H</i>)-ones as inhibitors of insulin-like growth factor-1 recpetor (IGF-1R)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2317</span><span class="NLM_x">–</span> <span class="NLM_lpage">2321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2317-2321&author=U.+Velaparthiauthor=M.+Wittmanauthor=P.+Liuauthor=K.+Stoffanauthor=K.+Zimmermannauthor=X.+Sangauthor=J.+Carboniauthor=A.+Liauthor=R.+Attarauthor=M.+Gottardisauthor=A.+Greerauthor=C.+Y.+Changauthor=B.+L.+Jacobsenauthor=J.+S.+Sackauthor=Y.+Sunauthor=D.+R.+Langleyauthor=B.+Balasubramanianauthor=D.+Vyas&title=Discovery+and+initial+SAR+of+3-%281H-benzo%5Bd%5Dimidazole-2-yl%29pyridine-2%281H%29-ones+as+inhibitors+of+insulin-like+growth+factor-1+recpetor+%28IGF-1R%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DWittman%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DStoffan%26aufirst%3DK.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DSang%26aufirst%3DX.%26aulast%3DCarboni%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DAttar%26aufirst%3DR.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DGreer%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DJacobsen%26aufirst%3DB.%2BL.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DBalasubramanian%26aufirst%3DB.%26aulast%3DVyas%26aufirst%3DD.%26atitle%3DDiscovery%2520and%2520initial%2520SAR%2520of%25203-%25281H-benzo%255Bd%255Dimidazole-2-yl%2529pyridine-2%25281H%2529-ones%2520as%2520inhibitors%2520of%2520insulin-like%2520growth%2520factor-1%2520recpetor%2520%2528IGF-1R%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2317%26epage%3D2321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wittman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoeckler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span> </span><span class="NLM_article-title">Novel 1<i>H</i>-(benzoimidazole-2-yl)-1<i>H</i>-pyridine-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">974</span><span class="NLM_x">–</span> <span class="NLM_lpage">977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=974-977&author=M.+D.+Wittmanauthor=B.+Balasubramanianauthor=K.+Stoffanauthor=U.+Velaparthiauthor=P.+Liuauthor=S.+Krishnanathanauthor=J.+Carboniauthor=A.+Liauthor=A.+Greerauthor=R.+Attarauthor=M.+Gottardisauthor=C.+Changauthor=B.+Jacobsonauthor=Y.+Sunauthor=S.+Hanselauthor=M.+Zoecklerauthor=D.+Vyas&title=Novel+1H-%28benzoimidazole-2-yl%29-1H-pyridine-2-one+inhibitors+of+insulin-like+growth+factor+I+%28IGF-1R%29+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWittman%26aufirst%3DM.%2BD.%26aulast%3DBalasubramanian%26aufirst%3DB.%26aulast%3DStoffan%26aufirst%3DK.%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DKrishnanathan%26aufirst%3DS.%26aulast%3DCarboni%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DGreer%26aufirst%3DA.%26aulast%3DAttar%26aufirst%3DR.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DHansel%26aufirst%3DS.%26aulast%3DZoeckler%26aufirst%3DM.%26aulast%3DVyas%26aufirst%3DD.%26atitle%3DNovel%25201H-%2528benzoimidazole-2-yl%2529-1H-pyridine-2-one%2520inhibitors%2520of%2520insulin-like%2520growth%2520factor%2520I%2520%2528IGF-1R%2529%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D974%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesario, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saroglou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolz, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sujka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkes, R.</span><span> </span><span class="NLM_article-title">1,3-Disubstitued imidazol[1,5-<i>a</i>]pyrazines as insulin-like growth factor-I receptor (IGF-IR) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1091-1097&issue=4&author=M.+J.+Mulvihillauthor=Q.-S.+Jiauthor=D.+Wernerauthor=P.+Beckauthor=C.+Cesarioauthor=A.+Cookeauthor=M.+Coxauthor=A.+Crewauthor=H.+Dongauthor=L.+Fengauthor=K.+W.+Foremanauthor=G.+Makauthor=A.+Nigroauthor=M.+O%E2%80%99Connorauthor=L.+Saroglouauthor=K.+M.+Stolzauthor=I.+Sujkaauthor=B.+Volkauthor=Q.+Wengauthor=R.+Wilkes&title=1%2C3-Disubstitued+imidazol%5B1%2C5-a%5Dpyrazines+as+insulin-like+growth+factor-I+receptor+%28IGF-IR%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26aulast%3DJi%26aufirst%3DQ.-S.%26aulast%3DWerner%26aufirst%3DD.%26aulast%3DBeck%26aufirst%3DP.%26aulast%3DCesario%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DM.%26aulast%3DCrew%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DForeman%26aufirst%3DK.%2BW.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DNigro%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%26aulast%3DSaroglou%26aufirst%3DL.%26aulast%3DStolz%26aufirst%3DK.%2BM.%26aulast%3DSujka%26aufirst%3DI.%26aulast%3DVolk%26aufirst%3DB.%26aulast%3DWeng%26aufirst%3DQ.%26aulast%3DWilkes%26aufirst%3DR.%26atitle%3D1%252C3-Disubstitued%2520imidazol%255B1%252C5-a%255Dpyrazines%2520as%2520insulin-like%2520growth%2520factor-I%2520receptor%2520%2528IGF-IR%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D4%26spage%3D1091%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hubbard, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamaung, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilsbacher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, G. S.</span><span> </span><span class="NLM_article-title">Pyrazolo[3,4-<i>d</i>]pyridimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5406</span><span class="NLM_x">–</span> <span class="NLM_lpage">5409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5406-5409&author=R.+D.+Hubbardauthor=N.+Y.+Bamaungauthor=F.+Palazzoauthor=Q.+Zhangauthor=P.+Kovarauthor=D.+J.+Osterlingauthor=X.+Huauthor=J.+L.+Wilsbacherauthor=E.+F.+Johnsonauthor=J.+Bouskaauthor=J.+Wangauthor=R.+L.+Bellauthor=S.+K.+Davidsenauthor=G.+S.+Sheppard&title=Pyrazolo%5B3%2C4-d%5Dpyridimidines+as+potent+inhibitors+of+the+insulin-like+growth+factor+receptor+%28IGF-IR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DR.%2BD.%26aulast%3DBamaung%26aufirst%3DN.%2BY.%26aulast%3DPalazzo%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DWilsbacher%26aufirst%3DJ.%2BL.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DBouska%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBell%26aufirst%3DR.%2BL.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26atitle%3DPyrazolo%255B3%252C4-d%255Dpyridimidines%2520as%2520potent%2520inhibitors%2520of%2520the%2520insulin-like%2520growth%2520factor%2520receptor%2520%2528IGF-IR%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5406%26epage%3D5409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><div class="note"><p class="first last">Recently OSI Pharmaceuticals and Exlexis have reported that their IGF-1R inhibitors, OSI-906 and XL-228, respectively, entered phase I clinical trials</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Recently+OSI+Pharmaceuticals+and+Exlexis+have+reported+that+their+IGF-1R+inhibitors%2C+OSI-906+and+XL-228%2C+respectively%2C+entered+phase+I+clinical+trials."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moore, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliewer, S. A.</span><span> </span><span class="NLM_article-title">Use of the nuclear receptor PXR to preedict drug interactions</span> <span class="citation_source-journal">Toxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2003&pages=1-10&author=J.+T.+Mooreauthor=S.+A.+Kliewer&title=Use+of+the+nuclear+receptor+PXR+to+preedict+drug+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DJ.%2BT.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26atitle%3DUse%2520of%2520the%2520nuclear%2520receptor%2520PXR%2520to%2520preedict%2520drug%2520interactions%26jtitle%3DToxicology%26date%3D2003%26volume%3D153%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gao, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkovec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span> </span><span class="NLM_article-title">Attenuating pregnane X receptor (PXR) activation: A molecular modelling approach</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm800832q&amp;key=10.1080%2F00498250601050412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm800832q&amp;key=17484516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm800832q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1ChsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=124-138&issue=2&author=Y.+D.+Gaoauthor=S.+H.+Olsonauthor=J.+M.+Balkovecauthor=Y.+Zhuauthor=I.+Royoauthor=J.+Yabutauthor=R.+Eversauthor=E.+Y.+Tanauthor=W.+Tangauthor=D.+P.+Hartleyauthor=R.+T.+Mosley&title=Attenuating+pregnane+X+receptor+%28PXR%29+activation%3A+A+molecular+modelling+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuating pregnane X receptor (PXR) activation: a molecular modelling approach</span></div><div class="casAuthors">Gao, Y.-D.; Olson, S. H.; Balkovec, J. M.; Zhu, Y.; Royo, I.; Yabut, J.; Evers, R.; Tan, E. Y.; Tang, W.; Hartley, D. P.; Mosley, R. T.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-138</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Recent studies have demonstrated that the pregnane X receptor (PXR) is a key regulator of cytochromes P 450 3A (e.g. CYP3A4 in human) gene expression.  As a result, activation of PXR may lead to CYP3A4 protein over-expression.  Because induction of CYP3A4 could result in clin. important drug-drug interactions, there has been a great interest in reducing the possibility of PXR activation by drug candidates in drug-discovery programs.  In order to provide structural insight for attenuating drug candidate-mediated PXR activation, we used a docking approach to study the structure-activity relationship for PXR activators.  Based on our docking models, it is proposed that introducing polar groups to the end of an activator should reduce its human PXR (hPXR) activity via destabilizing interactions in the hydrophobic areas of the PXR ligand-binding pocket.  A no. of analogs that incorporate these structural features then were designed and synthesized, and they exhibited significantly lower hPXR activation in a transactivation assay and decreased CYP3A4 induction in a human hepatocytes-based assay.  In addn., an example in which attenuating hPXR activation was achieved by sterically destabilizing the helixes 11 and 12 of the receptor is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBZSC0secQoLVg90H21EOLACvtfcHk0lhIX18tnjxLaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1ChsrY%253D&md5=400688510dd165a4a9632b6ba10bf267</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1080%2F00498250601050412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250601050412%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%2BD.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DBalkovec%26aufirst%3DJ.%2BM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DRoyo%26aufirst%3DI.%26aulast%3DYabut%26aufirst%3DJ.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DE.%2BY.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26atitle%3DAttenuating%2520pregnane%2520X%2520receptor%2520%2528PXR%2529%2520activation%253A%2520A%2520molecular%2520modelling%2520approach%26jtitle%3DXenobiotica%26date%3D2007%26volume%3D37%26issue%3D2%26spage%3D124%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Carboni, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadsell, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bol, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camuso, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurlburt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westhouse, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupnow, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, T. W.</span><span> </span><span class="NLM_article-title">Tumor development by transgenic expression of a constitutively active insulin-like growth factor-1 receptor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">–</span> <span class="NLM_lpage">3787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=3781-3787&author=J.+M.+Carboniauthor=A.+V.+Leeauthor=D.+L.+Hadsellauthor=B.+R.+Rowleyauthor=F.+Y.+Leeauthor=D.+K.+Bolauthor=A.+E.+Camusoauthor=M.+Gottardisauthor=A.+F.+Greerauthor=C.+P.+Hoauthor=W.+Hurlburtauthor=A.+Liauthor=M.+G.+Saulnierauthor=U.+Velaparthiauthor=C.+Wangauthor=M.-L.+Wenauthor=R.+A.+Westhouseauthor=M.+Wittmanauthor=K.+Zimmermannauthor=B.+A.+Rupnowauthor=T.+W.+Wong&title=Tumor+development+by+transgenic+expression+of+a+constitutively+active+insulin-like+growth+factor-1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarboni%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DA.%2BV.%26aulast%3DHadsell%26aufirst%3DD.%2BL.%26aulast%3DRowley%26aufirst%3DB.%2BR.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DBol%26aufirst%3DD.%2BK.%26aulast%3DCamuso%26aufirst%3DA.%2BE.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DGreer%26aufirst%3DA.%2BF.%26aulast%3DHo%26aufirst%3DC.%2BP.%26aulast%3DHurlburt%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DSaulnier%26aufirst%3DM.%2BG.%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DM.-L.%26aulast%3DWesthouse%26aufirst%3DR.%2BA.%26aulast%3DWittman%26aufirst%3DM.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DRupnow%26aufirst%3DB.%2BA.%26aulast%3DWong%26aufirst%3DT.%2BW.%26atitle%3DTumor%2520development%2520by%2520transgenic%2520expression%2520of%2520a%2520constitutively%2520active%2520insulin-like%2520growth%2520factor-1%2520receptor%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D3781%26epage%3D3787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wittman, D. M. B.; Balasubramanian, N.; Velaparthi, U.; Zimmermann, K.; Saulnier, G. M.; Liu, P.; Sang, X.; Frennesson, B. D.; Stoffan, K. M.; Tarrant, J.; Marinier, A.; Roy, S.</span><span> </span><span class="NLM_article-title">Preparation of 2-(4-substituted-2-oxo-1,2-dihydropyridine-3-yl)-benzimidazoles as novel tyrosine kinase inhibitors</span>. U.S. Patent US2004/044203 A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=D.+M.+B.+Wittman&author=N.+Balasubramanian&author=U.+Velaparthi&author=K.+Zimmermann&author=G.+M.+Saulnier&author=P.+Liu&author=X.+Sang&author=B.+D.+Frennesson&author=K.+M.+Stoffan&author=J.+Tarrant&author=A.+Marinier&author=S.+Roy&title=Preparation+of+2-%284-substituted-2-oxo-1%2C2-dihydropyridine-3-yl%29-benzimidazoles+as+novel+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWittman%26aufirst%3DD.%2BM.%2BB.%26atitle%3DPreparation%2520of%25202-%25284-substituted-2-oxo-1%252C2-dihydropyridine-3-yl%2529-benzimidazoles%2520as%2520novel%2520tyrosine%2520kinase%2520inhibitors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Saulnier, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frennessn, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velaparthi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struzynski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balimane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D.</span><span> </span><span class="NLM_article-title">2-(1<i>H</i>-Imidazol-4-yl)ethanamine and 2-(1<i>H</i>-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1702</span><span class="NLM_x">–</span> <span class="NLM_lpage">1707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1702-1707&author=M.+G.+Saulnierauthor=D.+B.+Frennessnauthor=M.+D.+Wittmanauthor=K.+Zimmermannauthor=U.+Velaparthiauthor=D.+R.+Langleyauthor=C.+Struzynskiauthor=X.+Sangauthor=J.+Carboniauthor=A.+Liauthor=A.+Greerauthor=Z.+Yangauthor=P.+Balimaneauthor=M.+Gottardisauthor=M.+Attarauthor=D.+Vyas&title=2-%281H-Imidazol-4-yl%29ethanamine+and+2-%281H-pyrazol-1-yl%29ethanamine+side+chain+variants+of+the+IGF-1R+inhibitor+BMS-536924"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaulnier%26aufirst%3DM.%2BG.%26aulast%3DFrennessn%26aufirst%3DD.%2BB.%26aulast%3DWittman%26aufirst%3DM.%2BD.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DVelaparthi%26aufirst%3DU.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DStruzynski%26aufirst%3DC.%26aulast%3DSang%26aufirst%3DX.%26aulast%3DCarboni%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DGreer%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DBalimane%26aufirst%3DP.%26aulast%3DGottardis%26aufirst%3DM.%26aulast%3DAttar%26aufirst%3DM.%26aulast%3DVyas%26aufirst%3DD.%26atitle%3D2-%25281H-Imidazol-4-yl%2529ethanamine%2520and%25202-%25281H-pyrazol-1-yl%2529ethanamine%2520side%2520chain%2520variants%2520of%2520the%2520IGF-1R%2520inhibitor%2520BMS-536924%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1702%26epage%3D1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">The potential disruption of glucose homeostasis by compound <b>10</b> arising from the inhibition of IR was evaluated in vivo in oral glucose tolerance test (OGTT). The test was performed in mice at both 50 and 100 mpk and found that significant glucose elevation was not observed prior to glucose challenge. However, after glucose challenge, an elevation of glucose level is observed at the 100 mpk dose that is very similar to the effect observed for compound <b>1</b> as reported in reference <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+potential+disruption+of+glucose+homeostasis+by+compound+10+arising+from+the+inhibition+of+IR+was+evaluated+in+vivo+in+oral+glucose+tolerance+test+%28OGTT%29.+The+test+was+performed+in+mice+at+both+50+and+100+mpk+and+found+that+significant+glucose+elevation+was+not+observed+prior+to+glucose+challenge.+However%2C+after+glucose+challenge%2C+an+elevation+of+glucose+level+is+observed+at+the+100+mpk+dose+that+is+very+similar+to+the+effect+observed+for+compound+1+as+reported+in+reference+10."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i9"><a href="/doi/suppl/10.1021/jm800832q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_38850"></div></div></div></div></div><hr /></hr><p class="last">Experimental details and analytical data for compound <b>10</b> are included. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800832q/suppl_file/jm800832q_si_001.pdf">jm800832q_si_001.pdf (1.44 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800832q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm800832q%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-19%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800832q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                205KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799437ebbb43ce8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
